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MOLECULAR DETERMINANTS OF VECTOR SPECIFICITY 
IN HIGHLANDS J VIRUS 
 
 
Highlands J Virus (HJV) is an understudied alphavirus that is closely related to western 
equine encephalitis virus (WEEV) and eastern equine encephalitis virus (EEEV).   HJV is not 
known to cause disease in humans or equids, but it is a known avian pathogen with potential to 
significantly disrupt commercial production flocks. 
These studies compared the sequences of multiple strains of HJV in order to better 
characterize and compare the range of available strains.  Strain B230, the prototype strain, was 
used to compare all other strains tested.  Strain 64A-1519 was most similar to B230 with 22 
nucleotide substitutions, only 5 of which resulted in a change in amino acid residues.  Strain 
WX3-2AP was the most divergent with 167 nucleotide changes resulting in 8 amino acid residue 
changes.  Four distinct lineages were identified through phylogenetic analysis.  Lineage 1 
consisted of strains B230 and 64A-15191.  Lineage 2 consisted of strains AB-80-9, RU-M-80-
259, and 73V-2540.  Lineage 3 consisted of strains W17791 and two GenBank strains (744-01 
and 585-01).  Strain WX3-2AP was the sole member of Lineage 4.   
Vector capacity studies for HJV in live Culex tarsalis mosquitoes have not been 
published prior to these experiments.  Cx. tarsalis mosquitoes were orally infected with one of 
four strains of HJV: B230, 64A-1519, WX3-2AP, or AB-80-9.  The heads and bodies of 
mosquitoes were separated and processed independently to assess viral presence by cytopathic 
effects (CPE).  The experiments were run in duplicate and at different times to ensure accuracy 
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of results.  Two infection patterns emerged: Lineage 1 strains had low infection and 
dissemination rates at all three time points, while Lineage 2 and 4 strains had high infection and 
dissemination rates which were more similar to those previously published for WEEV Imperial 
strain in Cx. tarsalis.  Virus titrations were performed on mosquito heads and bodies, and 
Lineage 4 strain WX3-2AP was found to have the highest average titers.  Mosquito bodies had 
the highest average titer on day 8 post infection and average titers for bodies ranged from 6.60 to 
7.26 log10 pfu equivalents/body.  Heads had no discernable pattern among titers or strains, but 
titers ranged between 6.01 and 6.80 log10 pfu equivalents/head.   
Saliva was collected from mosquitoes infected with Lineage 2 strain AB-80-9 to assess 
the potential presence of a salivary gland barrier resulting in lack of transmission.  Twenty-two 
of 49 mosquitoes tested transmitted detectible levels of virus, meaning 44.9% of orally infected 
mosquitoes were able to actively transmit the virus.  While the titer of the saliva on a per mL 
basis was impossible to compute since the volume of saliva could not be quantified, the titers of 
the samples collected ranged between 1.68 and 5.81 log10 pfu equivalents/saliva sample. 
By combining the data obtained by sequencing the strains with the data from the 
mosquito infections, a single amino acid difference between the attenuated Lineage 1 strains and 
the more virulent Lineage 2 and 4 strains was identified as being potentially responsible for the 
differences in infectivity.  The mutation was located at genome nucleotide position 8605, E2 
glycoprotein amino acid 69.  This change caused the non-polar glycine in the attenuated Lineage 
1 strains to be replaced with an acidic glutamic acid in the more virulent Lineage 2 and 4 strains.  
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CHAPTER 1: LITERATURE REVIEW 
 
 
Alphavirus- Virology and Genetics 
Genetics 
Like other alphaviruses, Highlands J Virus (HJV) has a single-stranded positive sense 
RNA genome.  The genomic RNA consists of two open reading frames (ORFs), 5’ and 3’ 
untranslated regions (UTR), and an intergenic UTR between the two ORFs.  The 5’ ORF 
contains the 4 non-structural proteins named nsP1, nsP2, nsP3 and nsP4, which are translated 
first.  The second ORF contains the structural genes, including the capsid (C), envelope 3 (E3), 
envelope 2 (E2), 6K, and envelope 1 (E1) genes, which are translated later in the replication 
cycle in preparation for assembling new virions. The RNA has both a 5’ cap and a 3’ poly-A tail, 
similar to cellular mRNAs [1].  The similarity between the alphavirus genome and cellular 
mRNAs has led to cellular processing and translation of the non-structural polyprotein coding 
region of the alphavirus as if it were an mRNA. 
 
 
Figure 1: Alphavirus genome map and known functions of individual resulting proteins 
 
Glycoprotein Structure and Function 
The alphavirus genome encodes for two envelope glycoproteins: E1 and E2.  These 
glycoproteins are anchored in the membrane of the virion, and are responsible for cellular 
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recognition, binding, and fusion.  The E1 glycoprotein forms a stable heterodimer with E2, and 
three of these heterodimers combine to form a trimeric spike that is visible on the surface of the 
virion [2].  It is thought that E1-E1 interactions maintain trimer stability [1].  Only upon fusion 
of the virus with the host cell during viral binding and entry does the trimer dissociate to form E2 
monomers and E1 homotrimers [3].  Alphaviruses have a total of 240 heterodimers that are 
assembled into 80 trimeric spikes.  
The alphavirus E1 glycoprotein is encoded by the E1 gene which is located in the 
structural ORF between 6K and the 3’ UTR.  The E1 glycoprotein has been shown to be vital for 
fusion with the host cell because cells that express E2 alone can bind but cannot fuse in low pH 
environments [1].  The alphavirus E2 glycoprotein is encoded in the structural ORF between E3 
and 6K and is responsible for cellular receptor recognition.  While E1 mutations have been found 
to alter host specificity, the E2 glycoprotein is essential for receptor recognition and is, as a 
result, nearly always involved in determination of host cell type.  Additionally, the majority of 
neutralization epitopes for alphaviruses map to the E2 glycoprotein since it is more surface 
exposed, and antibodies directed against E2 are often more neutralizing than antibodies directed 
against E1 [1].   
The structure of the E2 glycoprotein was elucidated in 2006 by Mukhopadhyay et al [4]. 
The study imaged the structure of Sindbis virus down to a 9Å resolution and showed that it has a 
long length with a leaf-like structure at the top of the spike.  They also found a very close 
association between E1 and E2 supported by a large number of contacts between the two in the 
leaf-like structure.  The images showed that the first 260 amino acids were a part of the 
ectodomain, the next 200 amino acids formed the stem, the lipid bilayer was crossed by about 30 
amino acids, and the protein was anchored by around 33 amino acids that interact with the core.  
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Studies elucidating the structures of E1 and E2 glycoproteins also help to clarify the 
structural context of work identifying residues that attenuate or alter alphaviruses in different 
ways. A number of these studies are listed in Table 1.  A tyrosine-to-histidine switch at the 
amino acid 18 of Ross River virus (RRV) greatly attenuated disease phenotype in a mouse model 
of rheumatic disease [5].  Research by Kinney et al. [6,7] found a single amino acid (R120) in 
the E2 glycoprotein was crucial for attenuation of Venezuelan equine encephalitis virus (VEEV).  
A reduction of VEEV midgut infection and dissemination in Aedes aegypti is linked to an 
isoleucine-to-phenylalanine mutation at position 207 of the E2 glycoprotein [8].   
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A change from glutamic acid (Glu) to arginine (Arg) at E2 position 193 and a change 
from threonine (Thr) to Arg at E2 position 213 are associated with 1992 VEEV subtype IC 
outbreak in Venezuela [11].  Moreover, mutations to positively charged amino acids on the 
surface of the E2 glycoprotein are associated with emergence of VEEV epizootics [12].  Amino 
acid position 213 is the most important in this region, leading to increased viremia in horses.  A 
tyrosine (Tyr) substitution at this location, however, leads to an attenuated phenotype with 
reduced viral loads, reduced viremia, and slower viral spread [13].  Mutation of amino acid 214 
from the glutamine (Gln) present in the McMillan strain of WEEV to the Arg present in less 
virulent Imperial strain caused significant loss of virulence in mice as compared to the parental 
virus [14].  It is important to note that the term “strain”, as utilized here, is defined as a genetic 
variant or single isolate of a virus.  A lineage, alternatively, refers to a genetically related group 
of strains or isolates.  A serine (Ser)-to-asparagine (Asn) mutation at position 218 in the VEEV 
genome is associated with an outbreak of a subtype IE strain [15].  Prior to this outbreak, only 
IAB and IC subtypes had been associated with major outbreaks of disease.  Researchers found 
that this mutation resulted in transmissibility by Ae. taeniorhynchus, a very common mosquito in 
the region, which led to greater transmission and infection rates.  Many of the residues involved 
in these phenotypic alterations are found in a close cluster at the very tips of the E2 spikes, and 
they provide evidence that these areas are directly associated with receptor binding.  
In addition to the more obvious, exposed locations involved in viral binding to host cells, 
other E2 residues were found to be important in the structure and function of the protein.  Two 
highly conserved glycines (Gly) at residues 415 and 416 were found to be necessary to bring the 
transmembrane helices of E1 and E2 together despite their bulky size [7]. The Gly at 415 and 
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416 are not involved in directly binding E1 and E2, but instead are responsible for alleviating 
steric hindrances.  
Other more synergistic E2 mutations requiring more than one amino acid difference have 
also been elucidated.  One of the most notable alphavirus mutations, E1-A226V, caused a shift in 
the vector specificity of chikungunya virus (CHIKV) from solely Ae. aegypti to both Ae. aegypti 
and Ae. albopictus on the island of La Reunion [16].  Upon further testing, it was found that 2 
additional E2 mutations are likely involved in enhancing the function of the E1-A226V mutation.  
The first mutation was a Gly-to-aspartic acid (Asp) shift at E2 position 60.  The second mutation 
was an isoleucine (Ile) that was replaced with a Thr at E2 position 211.  Both mutations 
synergistically aid in generating the high infectivity phenotype  [9].   
Early studies mapping the E2 glycoprotein by monoclonal antibody (MAb) elucidated 
several regions of the glycoprotein potentially involved in interactions with cellular receptors or 
antibody binding (Table 2).  A study by Strauss et al. [17] discovered a 50-amino acid region 
within the E2 glycoprotein of Sindbis virus (SINV) that contained a large number of 
neutralization determinants.  The region spans from amino acid 170 to amino acid 220, and 
contained a number of sites that, when mutated, changed the binding affinity of MAb specific for 
E2.  It was concluded that this domain is very important for the binding of the virus to cellular 
receptors since MAb blocked binding of the virus to the cells.  The study explored three epitope 
regions (A, B, and C) and escape mutants (genetic variants that can no longer be recognized by 
previously successfully-binding antibody due to a change in amino acid composition) were found 
for each. Epitope region A escape mutants were mapped at amino acid positions 3, 172, 181, 
190, 205, 214 and 216.  Epitope region B escape mutants were mapped to positions 184, and 
216. Amino acid 216 was found to be of particular interest since its involvement in both A and B  
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Table 2: Locations of monoclonal antibody binding sites 
Amino acid site in E2 Epitope Region Virus Reference 
3 Epitope Domain A SINV [15] 
62 Epitope Domain C SINV [18] 
96 Epitope Domain C SINV [18] 
159 Epitope Domain C SINV [18] 
172 Epitope Domain A SINV [17] 
181 Epitope Domain A SINV [17] 
182 Not specified VEEV [15,20] 
183 Not specified VEEV [15,20] 
184 Epitope Domain B SINV [17] 
190 Epitope Domain A SINV [17] 
199 Not specified VEEV [15,20] 
205 Epitope Domain A SINV [17] 
207 Not specified VEEV [15,20] 
214 Epitope Domain A SINV [17] 
216 Epitope Domain A/B SINV [17] 
216 Not specified RRV [19] 
232 Not specified RRV [19] 
233 Not specified RRV [19] 
234 Not specified RRV [19] 
246 Not specified RRV [19] 
247 Not specified RRV [19] 
248 Not specified RRV [19] 
249 Not specified RRV [19] 
250 Not specified RRV [19] 
251 Not specified RRV [19] 
342 Epitope Subdomain D VEEV [7] 
367 Epitope Subdomain D VEEV [7] 
 
epitopes was very decisive. Pence et al. [18] found epitope C to be in a completely different 
region from A and B, mapping amino acid residues involved in epitope C map to positions 62, 
96, and 159. A later study identified subdomain D that resided between residues 342 and 367 in 
VEEV [7].  Other studies also demonstrated the relative importance of these regions in the E2 
glycoprotein of RRV [19].  Amino acid positions 216, 232 to 234, and 246 to 251 were found to 
be the site of binding for MAbs and a change in charge at these sites resulted in the formation of 
escape mutants.  A study involving VEEV MAb escape mutants found positions 182, 183, 199 
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and 207 of particular importance, and two of the changes involved a change in charge resulting 
in escape [15,20].  It is clear that this region is involved in cell binding and that a change in the 
amino acids can have consequences both for cellular binding and the binding of antibody which 
can impact viral infectivity and cell specificity. 
 
Phylogeny 
The genus Alphavirus, (family Togaviridae) includes 31 species from seven distinct 
antigenic complexes; four complexes for the Old World and three complexes for the New World 
viruses. The New World complexes include EEE, WEE, and VEE.  Old world complexes include 
Barmah Forest (BF), Middelburg (MID), Ndumu (NDU), and Semliki Forest (SF).  Old World 
viruses cause arthralgia syndromes and are rarely fatal.  In contrast, only New World 
alphaviruses cause more severe disease characterized by encephalitis.  Viruses causing this 
syndrome include EEEV, WEEV, and VEEV.  However, not all New World viruses cause 
illness.  Pixuna (PIXV), Aura (AURAV), and Trocara (TROCV) viruses are not known to cause 
any serious human illness, and others such as Mayaro (MAYV) and Una (UNAV) viruses cause 
febrile illness similar to those found in the Old World [21]. 
Within the WEEV complex, there are 6 species: WEEV, HJV, Fort Morgan virus (FMV), 
AURAV, Sindbis virus (SINV), and Whataroa virus (WHAV) [22].  A further division within 
this subset can be made based on recombinant status: those that are derived from a historical 
recombination event (including WEEV, HJV and FMV), and those that are not a result of 
recombination (SINV, WHAV, and AURAV) [23].  WEE and HJV appear to be derived from 
the same recombination event between EEEV and SINV, while FMV appears to be the only 
known virus in its own lineage [22]. 
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Highlands J Virus 
Discovery 
HJV is unique within the WEEV complex in that it is found in the eastern United States.  
The first known occurrences of HJV were in June 1960 when four isolations were made: two 
from blue jays (Cyanocitta cristata) (Strains B230 and B213), one from a sentinel mouse (Mus 
musculus Strain SM-66), and one from a pool of Ae. taeniorhynchus (Strain AR-38K) [24].  
Later in 1960, another isolate was made from a catbird near Tampa Bay, Florida [25]. HJV was 
initially described as an “eastern variant of WEEV” due to the cross-reactivity of serum 
antibody, though this designation was later changed when more advanced sequencing techniques 
became available [26]. No further isolations were published until 1964, when six were made in 
Hillsborough County, Florida during a concurrent epizootic of EEEV [27]. 
 
Disease 
Historically, equine encephalidities are some of the oldest viruses identified in North 
America.  EEEV was first recognized in 1933 as the cause of encephalitis in horses [28], and the 
first outbreak among humans was reported in 1938 [29].  Later, in 1937 and 1938, over a third of 
a million WEEV cases were reported with a 20% case fatality rate in 22 western states [30]. In 
 SINV (GenBank #NC 001547.1)
 WHAV (GenBank #HM147993.1)
 AURAV (GenBank #NC003900.1)
 FMV (GenBank #NC013528.1)
 HJV B230 (GenBank #GQ227789.1)






1938, the first isolation of WEEV was made from a human [31].  Three years later, in 1941, the 
largest human epidemic of WEEV occurred in the north central US [32].  
HJV has not been attributed to any notable infection in horses or humans and it generally 
is considered medically unimportant. Two known cases exist as exceptions.  The first case was 
an isolate from a horse that died of encephalitic disease in Florida in 1964 [27].  The virus, strain 
64A-1519, was initially classified as being an eastern variant of WEEV.  However, 
characterization using hemagglutination-inhibition (HI) testing later showed the virus to be HJV 
[33]. This is the only documented case of equine illness attributed directly to HJV by virus 
isolation.  The second documented case of HJV disease was during an outbreak of Saint Louis 
encephalitis virus (SLEV) in humans in Florida from 1990-1991.  Patients with febrile illness, 
headache or other central nervous system abnormalities were tested for a number of agents by 
HI, indirect fluorescent antibody (IFA) testing, and immunoglobulin M (IgM) ELISA.  Four 
patients with presumptive SLEV had elevated IgM antibodies to HJV in paired serum samples, 
and the cases were treated as concurrent or dual infections [34].  This is the first, and so far only, 
known reported case of acute HJV infection in humans.  The authors of this study, however, 
attributed all the symptoms of disease to SLEV.  Several other accounts have linked encephalitic 
illness to HJV by antibody, however the lack of virus isolated from these cases rendered the 
diagnosis uncertain [35,36].   
While HJV is not typically a human or equine pathogen, its emergence as an avian 
pathogen is well documented. One of the first studies identifying HJV as a potential threat to 
birds documented a flock of turkeys in North Carolina infected with HJV [37]. The flock 
deteriorated despite being given antibiotics, with thousands of birds dying daily. The etiological 
agent remained unknown until electron microscopy identified togavirus-like particles in the stool 
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of the birds.  Blood samples showed seroconversion for HJV, but not for EEEV or other common 
avian pathogens. Previous studies showed EEEV could be transmitted by feather plucking, 
cannibalism [38], and oral exposure [39], which may be possible routes of transmission for HJV 
as well.  The isolation of HJV from the feces of infected birds led researchers to conclude  there 
is transmission potential through a fecal-oral route among the flock [37]. 
Experimental infection of young turkeys with HJV resulted in varying degrees of illness 
including depression, somnolence, lack of appetite, and leg paralysis [40].  Viremia was noted on 
day 1 post inoculation, and 27% of inoculated animals died between days 2 and 3 post infection.  
Virus was recovered from the brains and bursae of all dying animals.  No gross lesions were 
noted in this study.  However, microscopic lesions nearly identical to those in birds inoculated 
with EEEV were noted in the bursa, thymus, spleen, heart, pancreas, and kidney. 
Another study documented a severe drop in egg production in a flock of turkeys naturally 
infected with HJV.  Egg production dropped as much as 72.6% in a breeder flock of turkeys over 
a 96 hour period, and HJV was isolated from the trachea of birds in the flock [41].  Egg 
production never returned to greater than 50% and the animals often laid small, soft or shell-less 
eggs.  
Chukar partridges that became naturally infected with HJV showed symptoms including 
leg weakness, head and neck tremors, somnolence, erratic behavior, and stumbling [42].  
Morbidity and mortality neared 35% during the 2-week duration of the outbreak in 1992.  The 
spleens of all ill animals showed signs of necrosis and depletion of lymphocytes.  Additionally, 
myocardial and intestinal abnormalities and necrosis were also noted.  One bird had lesions in 
the brain and swelling of the meninges.  Interestingly, an earlier outbreak of similar disease was 
cited at the same farm in 1980, but the etiological agent was listed as WEEV.  Given the history 
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of confusion about the “eastern variant of WEEV,” it is possible that the agent in that outbreak 
was also HJV. 
It is clear that HJV has the potential to cause costly loss of commercial avian flocks due 
to natural infection of animals penned outdoors or in enclosures with the potential for mosquito 
entry.  The severity and symptoms of the disease appear to be very similar to those of EEEV in 
birds.   
 
Distribution 
The only other alphavirus currently found on the east coast of the United States is EEEV, 
which has a nearly identical range to that of HJV.  Both viruses are primarily vectored by 
Culiseta melanura and are amplified by passerine and wading birds, and so they have nearly 
identical geographic holds within North America [43,44].  However, HJV has only been 
described in eastern North America, while EEEV has been described in North, Central, and 
South America. 
 
Figure 3: States with reported WEEV and EEEV activity [47] 
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WEEV has a very different range and transmission cycle from HJV.  WEEV is found in 
both North and South America like EEEV, but only in the western portions of the continents.  Its 
primary vector is Culex tarsalis in North America [45].  Similar to HJV and EEEV, the primary 
amplifying host for WEEV is passerine birds.  Researchers have theorized that the absence of 
WEEV in the eastern US is due, at least partially, to the fact that Cx. tarsalis is rare east of the 
Mississippi River [46]. 
 
Invertebrate Vectors 
Most research looking at alphavirus transmission cycles on the east coast of the United 
States has focused on EEEV, but HJV is assumed to share a similar transmission cycle.  
However, despite the many studies of the ecology of EEEV (or HJV) transmission, many of the 
details regarding the transmission cycle remain enigmatic. In North America, two 
epidemiological cycles have been proposed.  The inland cycle exists predominantly in Red 
Maple swamps and the surrounding woodlands, and exhibits sporadic viral activity [48,49].  The 
costal cycle is more regular, occurring annually from New Jersey to Maryland in Atlantic White 
Cedar swamps and salt-marsh regions [50,51].   
HJV has been isolated from numerous mosquito species along the eastern coast of the 
United States.   During a 6-year study in Rhode Island from 1995 to 2000, 109 isolates were 
obtained from pools of Cs. melanura [44,52,53].   Cs. melanura typically dwells in swamps and 
larvae are often found in water-filled spaces beneath the trees [54].  Adults feed primarily on 
avian species within close range of the swamps, but also have been documented to feed on white 
tailed deer (Odocoileus virginianus), domestic cow (Bos taurus), and humans [55-58].  The 
distribution of Cs. melanura ranges from Florida to Maine along the eastern coast of the United 
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States and west to the Mississippi River.  It appears to be missing from the Appalachian 
mountains in West Virginia, Pennsylvania, and portions of the Carolinas and Virginia in the 
higher elevations [46]. 
A poorly studied facet of the HJV and EEEV transmission cycle is transmission to 
equines and humans.  There are two common hypotheses that may explain the transmission of 
HJV from its normal passerine host to dead-end hosts.  While Cs. melanura mosquitoes are 
mainly ornithophilic, some biting of other hosts as previously noted may account for intermittent 
transmission to mammals.  “Bridge” vectors may enter the cycle by biting viremic birds and then 
later biting their own more typical mammalian hosts.  
Several studies have suggested that other “bridge” vectors enter the cycle to transmit the 
virus to mammalian hosts.  Dry ice-baited Centers for Disease Control and Prevention (CDC) 
light traps were used in southeastern Connecticut to collect mosquitoes during the 1996 EEEV 
epizootic [59].  Nineteen isolations of HJV were made from 6 mosquito species, including Ae. 
canadensis, Ae. cantator, Ae. vexans, Cx. pipiens, Cs. melanura, and Cs. morsitans.  The 
majority of isolations made were from Cs. melanura and Cx. pipiens. In other studies, HJV has 
been isolated from Coquillettidia perturbans, Ae. infirmatus [60], Ae. atlanticus-tormentor [60], 
Ae. taeniorhynchus [24,60], Ae. cinereus [61], Anopheles crucians [60], Cx. nigripalpus [60],  
and Cs. morsitans [61], demonstrating the potential of the spread of HJV outside of the confines 
of the range of Cs. melanura. 
Cx. tarsalis is a New World mosquito species and the primary enzootic vector of WEEV.  
The range of Cx. tarsalis is “western North America, from central Mackenzie Valley south to 
Mexico, east to southwestern Ontario and Florida” [62].  It is mainly found on the grasslands, 
especially the short grass prairies and high plains of the western states but it also has been found 
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in floodplains and woodlands where water can be found standing for a long period of time [63].  
Very rarely, Cx. tarsalis has been found east of the Mississippi River, with occurrences 
documented in New Jersey [64] and southeastern Virginia [65]. 
 
Figure 4: Estimated host ranges of Cs. melanura (red), Cx. tarsalis (blue), and overlap (purple).  
Adapted from Darsie and Ward, 2nd edition [46] 
 
 
Unlike other Cx. species, Cx. tarsalis prefers relatively clean sources of water for 
oviposition.  Specific habitats include constructed wetlands and rice fields [66], hoof prints in 
fields [66] and abandoned swimming pools [67].  Additionally, this species is euryhaline and has 
been collected in saline surface pools [68]. 
 While Cx. tarsalis was originally considered to be an avian feeder, multiple studies have 
proven Cx. tarsalis to be a catholic feeder. A 1964 study identified the sources of 204 blood 
meals taken by Cx. tarsalis in a grassland area near Manhattan, Kansas.  Bloodmeal sources 
included cows, sheep, humans, rabbits, hogs, dogs, and birds [69].  In this particular study, birds 
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were not the principal source of the blood meals.  Another study used Cytochrome oxidase I 
(COI) gene sequences to identify sources of Cx. tarsalis blood meals by comparison with the 
Barcode of Life Database (BOLD).  Avian species accounted for about 75% of meals, but a large 
number of mammals and a few reptiles were also identified [70].  Within the avian species most 
frequently identified, no preference for specific taxa or sets of behaviors or habitats were found.  
Generalist behavior among Cx. tarsalis females illustrates the potential of this species to serve as 
a bridge vector to transmit a primarily avian virus such as WEEV to dead-end mammalian hosts. 
Another proposed vector is the avian mite, such as the chicken mite (Dermanysus 
gallinae), which has been able to acquire EEEV in a blood meal from a viremic chick and 
transmit the infection to a naïve chicken [71].  However, this is likely not as involved in the 
transmission cycle as the mosquito since they are species specific and would not spread the virus 
to other mammals. 
 
Vertebrate Hosts 
Due to the assumed similarity to the maintenance cycle of EEEV, HJV is presumed to 
have an avian vertebrate reservoir.  HJV circulation in mist-netted birds was evaluated in New 
York between 1986 and 1990 in various habitats surrounding a large natural swamp [72]. Eight 
isolations of HJV from seven different avian species including gray catbird, red-eyed vireo, 
downy woodpecker, white-throated sparrow, song sparrow, and veery were made. Seven of the 
eight isolations were made during the August 1986 HJV epiornitic.  Over the course of the 5-
year study period, HJV antibodies were detected in 7.7% of avian samples.  This study increased 
the number of avian species from which HJV had been isolated to 33 species in 13 different 
families.  McLean et al. [73] described ten criteria for the ideal vertebrate host, listed in Table 3.  
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Grey catbirds fulfill the criteria for the “perfect” vertebrate reservoir host for HJV, and they are 
largely found in regions with endemic HJV circulation.  The status of this species as a reservoir 
is further supported by another study in southeastern Massachusetts where 14 HJV isolations 
were made from the blood of gray catbirds [74].  American robins (Turdus migratorius 
Linnaeus) have also been studied as a potential competent reservoir [55,74,75].  In contrast, 
another species, song sparrows, may play a role in the initiation of epiornitics [72]. 
 
Table 3: Criteria for the “perfect” vertebrate host [73] 
Number Criteria 
1 a relatively abundant population during the transmission season 
2 fairly high reproductive rate so that large numbers of young susceptible animals are present for an extended period of time during the transmission period 
3 an ecologic association with vector species 
4 local mobility 
5 a daily activity pattern conducive to vector feeding 
6 attractiveness to vector species 
7 tolerance to vector feeding 
8 susceptibility to the virus 
9 adequate response to virus infection (high titer and duration of viremia) to infect subsequent vectors 




There are three methods for detecting disease caused by HJV: identification of HJV 
specific antibody, identification of HJV antigen, and identification of HJV nucleic acid.  
Detection of HJV viral ribonucleic acid (RNA) is the most specific way of confirming HJV 
infection, but alphaviral RNA can be difficult to identify in blood samples due to the limited time 
course of viremia, so often antibody testing is the only method available.  Serum antibody 
samples taken during acute illness and during convalescence can be used to confirm infection by 
comparison of IgM and immunoglobulin G (IgG) levels over time. 
The earliest antigen test for HJV was Enzyme Immunoassay (EIA).  The test was 
developed in 1984 using pools of Ae. triseriatus inoculated intrathoracically with HJV strain 
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Connecticut Sp72-666 [76].  The assay was sensitive enough to detect antigen from a single 
infected mosquito in a pool of 99 uninfected specimens and the specificity of the assay was 
reported near 100%.  Another advantage of this test is the ability to test large numbers of 
mosquito pools in the microplate format.  
Other early tests included complement fixation (CF), HI, and radioimmune precipitation 
(RIP) tests.  Because the E2 glycoprotein of HJV shares many antigenic determinants with 
WEEV, CF tests had some degree of cross-reactivity between WEEV and HJV.  WEE antibody 
weakly recognized HJV antigen in some cases, but HJV antibody had strong detection against 
WEEV antigen in all cases, nearly equal to that of WEEV antibody [77].   An early study showed 
this cross-reactivity through the testing performed during the isolation of strain 64A-1519 from a 
Florida horse in 1964, and results are shown in Table 4 [27].  None of the published tests showed 
cross-reactivity with EEEV.  These tests indicate a complicated relationship between WEEV and 
HJV in which HJV antibody always reacts against WEEV antigen, but WEEV antibody does not 
always recognize HJV antigen. 
Serological tests are dependent upon the particular glycoprotein under consideration: E1 
or E2 [78].  In HI tests, antibodies produced against WEE E1 and either WEEV or HJV E2 
reacted against both HJV and WEEV antigen, sometimes weakly and sometimes at comparable 
levels.  HJV E2 antibodies did not react efficiently or specifically in either the HI or RIP tests.  
The only specific antibody interactions noted were those among antibodies produced against 
WEEV E2 in RIP tests and those produced against HJV E1 in RIP and HI tests.  These results 
show the possibility of misinterpretation of WEEV or HJV diagnosis. 
The more specific plaque reduction neutralization test (PRNT) demonstrated 3-fold 
differences in titers of HJ B230 antibody tested against WEEV Flemming and R-43738 antigens 
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and those same antigens tested against their own, specific antibody [79].  Interestingly, HJV 
antibodies were unable to neutralize four other WEEV strains to any extent.  When antibodies 
made against several WEEV strains were tested against HJV B230 antigen, two were able to 
neutralize HJV B230 antigen as effectively as antibody made specifically against HJV B230.  
The rest of the WEEV antisera showed 3- to 4-fold lower titers against HJV.  This indicates that 
there is a unidirectional neutralization phenomenon in which HJV antibody weakly recognizes 
only some strains of WEEV, but WEEV antibody consistently recognizes HJV, even if at a 
slightly reduced efficiency.   
Table 4: Results from CF and HI Testing in two research studies 
TEST: CF WEEV Antibody HJV Antibody 
WEEV Antigen 64 40 
HJV Antigen 16 not tested 
Results from CF testing of HJV 64A-1519 and WEEV Flemming [27] 
   TEST: CF WEEV Antibody HJV Antibody 
WEEV  Antigen 128/128 32/32 
HJV Antigen 0 32/8 
CF Results expressed as serum titer/antigen titer; 0 = <8/<8 [77].  Both serum and antigen 
were titrated for this experiment. Serum titer is the dilution of serum containing specific 
antibody at which the solution retains the minimum level of activity needed to neutralize the 
antigen.  The antigen titer is the minimum dose of antigen needed to cause antibody to bind to 
the antigen and show neutralization.  Both are expressed as the reciprocal of the dilution value.  
   TEST: HI WEEV Antibody HJV Antibody 
WEEV Antigen 2560 80 
HJV Antigen 1280 320 
Results from HI Testing of HJV and WEEV [77] 
 
Although many enzyme linked immunosorbent assays (ELISAs) have been developed for 
EEEV, WEEV, and VEEV, an extensive search revealed no published ELISA test for HJV.  It is 
likely that the lack of appreciable disease caused by HJV in either humans or equids has limited 
the demand for rapid ELISA testing for HJV.   
	  19	  
Table 5: Results of Serum dilution plaque-reduction neutralization tests with viruses of the 
WEEV antigenic complex [79] 
    Serum Antibody: 
Virus Strain Fleming McMillan R-43738 AG-80-646 BeAr 102091 Y62-33 B230 
WEEV Fleming 2560 40 640 40 160 40 40 
WEEV McMillan 2560 1280 2560 640 640 2560 0 
WEEV R-43738 2560 40 5120 320 160 160 40 
WEEV AG-80-646 1280 640 640 1280 320 640 0 
WEEV BeAr 102091 320 20 160 80 320 80 0 
WEEV Y62-33 160 320 80 160 320 2560 0 




The HJV genome is 11,526 nucleotides in length, excluding the 5’ cap and poly-A tail, 
and encodes 3,686 amino acids [23].  The non-structural proteins alone account for 63.8% of the 
genome, being 7,350 nucleotides or 2,450 amino acids long.  The shorter structural proteins 
accounted for 32.2% of the genome, being 3,708 nucleotides or 1,236 amino acids in length.  




Figure 5: HJV genome organization [23] 
 
The genome of HJV is similar to that of its nearest genetic relatives, EEEV and WEEV 
(Table 6).  In comparison, HJV is intermediate in length as it is 18 nucleotides longer than 
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WEEV’s genome of 11,508 nucleotides, and 156 nucleotides shorter than EEEV’s genome of 
11,682 nucleotides [23]. HJV has the smallest coding capacity of the three viruses.  WEEV has a 
75% nucleotide identity and 87% amino acid identity with HJV, making it HJV’s closest relative.  
Additionally, HJV and WEEV share the same abrupt genetic change in the structural genes, 
showing they were both derived from the same ancestral recombination event [80].  The C 
protein of WEEV and HJV is similar to EEEV, while the E1 and E2 glycoproteins are most 
homologous to an ancestral Sindbis-like virus.  Comparison between EEEV and HJV is more 
difficult due to that recombination event, as strong similarity between the two viruses ends 
abruptly in the E3 gene [23]. 
 In pairwise comparisons between HJV, EEEV and WEEV, nonstructural protein 1 (nsP1) 
was found to have the most genetic similarity among all three at 86-93%.  This was followed by 
nonstructural protein 4 (nsP4) (88-90%), nonstructural protein 2 (nsP2) (84-89%), and 
nonstructural protein 3 (nsP3) (69-73%).  nsP3 is truncated in HJV in comparison to both WEEV 
and EEEV, thus it has a lower degree of homology [23].  The N-terminal region of nsP3 is 
largely conserved among the three viruses, but the C-terminal variable region of HJV has only 
52% and 44% identity with WEEV and EEEV, respectively.  HJV also contains the Opal stop 
codon (UGA) between nsP3 and nsP4 proteins which results in production of either nsP123 or 
nsP1234 early in translation [1]. 
Like other alphaviruses whose cycles are dependent on the interplay between arthropod 
vectors and vertebrate hosts, HJV has a higher degree of genetic stability and a slower rate of 
mutation and evolution than other, non-arthropod-borne viruses [81,82].  The amount of virus 
replication has been suggested to be related to the length of the transmission season [83].  This 
would mean that arthropod-borne alphaviruses have fewer cycles per year because the 
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transmission season, and hence time for viral replication in the vertebrate host, is shorter 
resulting in less potential for genetic change and mutation.  A study looking at a 1,200 nucleotide 
region in 19 strains of HJV found that there was very limited genetic diversity, similar to the 
patterns seen in EEEV [83,84]. It was proposed that because the transmission cycle required the 
vector and vertebrate host to interact at the proper time and in the same location, arboviruses 
likely exist in conditions of disequilibrium leading to many strains going extinct due to imperfect 
conditions, and not lack of fitness [83].  Overall, however, HJV strains share a large degree of 
homogeneity and genetic stability. 
 
Table 6: Genetic relatedness of HJV, WEEV, and EEEV by gene.  Adapted from Allison and 
Stallknecht, 2009 [23] 
Genomic 
Region 
HJV WEEV EEEV 













5' UTR 45 0 48 0 +3 95%   46 0 +1 77%   
nsP1 1,599 533 1,599 533 0 80% 93% 1,599 533 0 75% 86% 
nsP2 2,382 794 2,382 794 0 75% 89% 2,382 794 0 72% 84% 
nsP3 1,545 515 1,596 532 +51 69% 73% 1,677 559 +132 54% 69% 
nsP4 1,824 608 1,824 608 0 74% 90% 1,824 608 0 73% 88% 
Intergenic 
Region 44 0 47 0 +3 80%   66 0 +22 54%   
Capsid 777 259 777 259 0 78% 90% 783 261 +6 75% 88% 
E3 180 60 180 60 0 75% 90% 189 63 +9 51% 56% 
E2 1,269 423 1,269 423 0 72% 85% 1,260 420 -9 47% 45% 
6K 165 55 165 55 0 78% 81% 171 57 +6 47% 40% 
E1 1,317 439 1,317 439 0 77% 89% 1,323 441 +6 57% 51% 
3'UTR 379 0 304 0 -75 82%   362 362 -17 55%   
TOTAL: 11,526 3,686 11,508 3,703 -18     11,682 3,736 +156     
AVERAGE:           75% 87%       66% 73% 
nt= nucleotides 
      AA= Amino Acids 
      nt diff= difference in nucleotide number 
      % ID nt= Percent identity of nucleotides 
      % ID AA= Percent identity of amino acids 
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 An important first step in examining the relationships between HJV strains and the 
closely related viruses WEEV and EEEV was to evaluate genomic sequences.  Genetics indicate 
a closer link to WEEV due to the recombinant status of both HJV and WEEV.  HJV shares a 
close relationship with EEEV due to the near identity of their transmission cycles. This work was 
designed to aid in understanding these relationships and perhaps help provide insights into how 
HJV spans the gap between EEEV and WEEV in terms of transmission cycles and genetics. 
 
 
Materials and Methods 
 
Cell Culture 
All cell culture stocks were received from central cell culture at the CDC Division of 
Vector Borne Infectious Disease (CDC, Fort Collins, CO). 
 
Complete Media/Mosquito Media 
Fetal bovine serum (FBS, Atlas Biologicals, Fort Collins, CO) was prepared for use by 
heat-inactivation at 56°C for 30 minutes and was aliquoted into 50 mL conical centrifuge tubes 
(Corning Incorporated, Corning, NY).  The aliquots held frozen at -20°C until use in media 
preparation. 
Liter bottles of Dulbecco’s Modified Eagle Medium (DMEM), (Life Technologies, 
Grand Island, NY) were obtained, and 100 mL of  medium was removed and discarded.  Heat-
	  23	  
inactivated FBS was added to the DMEM to a final concentration of 10%.  A 10 mL aliquot of 
100x PenStrep (Life Technologies) was added to prevent bacterial growth and contamination of 
cell cultures.  Complete media was held at 4°C and discarded after 14 days.  For the processing 
of mosquito samples, 1 mL of Gentamycin (50µg/mL) and 1mL of Fungizone (1µg/mL) were 
added to complete media to produce mosquito media.  Mosquito media was also held at 4°C and 
discarded after 14 days. 
 
Virus Strains  
Seven strains of HJV were obtained from the CDC Arboviral Diseases Branch inventory.  
Virus-specific details are listed in Table 7. 
Table 7: Highlands J Virus details 
Virus Strain Isolated From Date Location Passage History 
HJV 64A-1519 Horse brain 1964 Hillsborough County, Florida P4SM1V1 
HJV AB-80-9 Horse blood 1980 New Jersey P?C2SM1V1 
HJV B230 Cyanocitta cristata (Blue Jay) 1960 
Archibold Biological Station, South 
Florida P5SM3V1 
HJV W17791 
Alectoris graeca (Rock 
Partridge) 1965 Maryland P?SM1WC1DE1SM1V1 
HJV 
RU-M-80-
259 Cs. melanura 1980 New Jersey P?C2SM1V1 
HJV 73V-2540 Cs. melanura 1973 Massachusetts P?WC1DE1SM1V1 
HJV WX3-2AP Cs. melanura 1963 Waycross, GA P?DE1V1 
      GenBank Strains: 
 
Virus Strain Isolated From Date Location Passage History 
HJV 585-01 Red Tailed Hawk brain 2001 Georgia UNKNOWN 
HJV 744-01 Barred Owl brain 2001 Georgia UNKNOWN 
HJV B230 Blue Jay Blood 1960 Florida UNKNOWN 
 
Virus Propagation  
All virus strains were individually propagated in 150 cm2 flasks (Corning Incorporated, 
Corning, NY) confluent with African green monkey kidney cells (Vero).  Viruses were diluted in 
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complete media to a final volume of 2 mL and were used to infect cells at a multiplicity of 
infection (MOI) of .01.  Flasks were incubated for 1 hour to allow virus binding, with gentle 
rocking every 15 minutes to ensure that the monolayer did not develop dry spots.  After the hour 
incubation, the cells were rinsed with Dulbecco’s Phosphate Buffered Saline (DPBS) (Gibco, 
Life Technologies) three times to remove unattached viral particles.  A 25 mL aliquot of 
complete media was added and flasks were incubated at 37°C.  Flasks were checked daily for 
signs of CPE and supernatants were harvested at approximately 50% CPE (48 to 72 hours).  For 
long term storage, supernatants were diluted 1:1 in heat-inactivated FBS and were held at -80°C 
in gasketed cryovials (Sarstedt, Nümbrecht, Germany). 
 
Plaque Assay Protocol  
In order to determine virus concentration (titer), plaque assays were performed.  A series 
of 8, 1:10 dilutions in 1.7 mL microfuge tubes (Corning) were set up in duplicate for each virus 
titrated.  To each tube, 270 µL of complete media was added.  A 30 µL aliquot of stock virus was 
added to the first tube of each series.  The samples were vortexed to ensure homogenization, and 
then 30 µL of diluted virus was taken from the first tube and added to the second tube.  Samples 
were again vortexed, and the dilutions continued to a final dilution of 10-8. 
Six-well tissue culture treated plates (Corning) confluent with Vero cells were labeled 
with the virus being titrated, the replicate, and the date.  The media was poured off the plates and 
250 µL of each diluted virus was added to the individual wells of the plate, beginning with the 
10-8 dilution.  Each plate contained dilutions from 10-3 to 10-8.  Plates were then incubated at 
37°C for one hour with gentle rocking every 15 minutes. 
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In a 1 liter bottle, 3.2 grams of Gene Mate LE Agarose powder (Bioexpress, Kaysville, 
UT) was added to 80 mL water to make a 4.0% agarose overlay stock.  This mixture was 
microwaved until boiling and all of the agarose was melted.  Pre-warmed complete medium kept 
at 42°C was added to the melted agarose to bring the total volume of the liquid to 800 mL to 
produce a 0.4% overlay media.  This overlay solution was allowed to cool to 42°C.  At the end 
of the hour-long incubation, 4 mL of agarose overlay solution was added to each well of the 6-
well plates.  Plates were kept in the biosafety cabinet at room temperature until the agarose 
began to solidify, at which point plates were transferred to 37°C incubators for 72 hours. 
A solution of 0.25% liquid crystal violet (Sigma, Saint Louis, MO) in 40% methanol 
(Fisher Scientific, Houston, TX) was prepared in advance as a fixative.  In a biosafety cabinet, 
agarose plugs were removed from the cell plates into a waste tray using a stainless steel spoonula 
(Fisher Scientific) and gentle pressure.  Crystal violet fixative (3-4 mL) was added to each well 
and additional fixative was added to the spaces between the wells.  Plates were held at room 
temperature in the fixative for a minimum of 10 minutes.  Plates were carefully flipped to ensure 
that fixative coated all surfaces of the plate including the lid interior, and then were rinsed under 
a gentle stream of warm water.  Plates were then left to dry before counting plaques.   
Once plates had dried, titers were determined using the following procedure.  Starting 
with wells that contained between 10 and 75 plaques, the number of plaques were counted.  
Typically, there were only one or two wells with a countable number of plaques, as most wells 
either contained too many plaques to count or no plaques at all.  The number of plaques in a 
countable well was multiplied by 4, to adjust for the volume used in this assay so the final titer is 
expressed per 1 mL.  That number was then multiplied by the reciprocal of the dilution of that 
well.  For example, if there were 15 plaques in the 10-7 well, the final titer of the virus would 
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have been 60 x 107, or 6.0 x 108.  Since each virus was titrated in duplicate, the average of the 
two titers was calculated to determine the final titer. 
 
RNA Extractions 
RNA extractions were performed using QIAamp Viral RNA Mini Kits (Qiagen, 
Valencia, CA) using the supplied protocol for purification of viral RNA using a microcentrifuge.  
A 140 µL aliquot of viral supernatant was extracted according to the kit’s protocol, and RNA 
was eluted in a final volume of 60 µL of Buffer AVE.  Following extraction, all RNA samples 
were quantified using the Qubit platform and the RNA BR protocol (Life Technologies).  Viral 
RNA was stored at -20°C until use. 
 
Agarose Gels 
For each agarose gel produced, 1.5 grams of Low EEO/Multipurpose/Molecular Biology 
Grade Agarose (Fisher Scientific) was mixed with 150 mL of 1x TAE buffer (Fisher Scientific) 
and 30 µL of Cybersafe DNA Gel Stain (Life Technologies).   This mixture was heated until 
melted in a microwave.  Once melted, the agarose was allowed to cool for 10 minutes or until the 
bottle was cooled enough to handle. The gel was poured into prepared molds and cooled until 
solidified.  Gels were then stored at 4°C in a closed Tupperware container until used (for a 




Table 8: Primers used to amplify and sequence HJV strains 
HJV Primer Name 
(location in HJV 
genome) Primer Sequence (5' to 3') 
HJV 77 FWD ACA GCC CGT TCG TCA AGT 
HJV 736 FWD TTA CGG CCG ACA AAC AAG A 
HJV 1568 FWD TAC CGC CTC TGC TCC CCG AAA TAG 
HJV 2158 FWD CGT CCG GCT GCA CCC TTG AAA 
HJV 2880 FWD GCT AAC CCG CAC TGA AAA A 
HJV 3495 FWD GGG CCA AAC AGA CTA CAG CGA CTT 
HJV 4038 FWD TCG CGT CAT TCG GGG AGA TA 
HJV 4333 FWD GTG TCG ATC CCG CTG CTG TCA ACT 
HJV 4852 FWD TTA CGC GCA GCA AAG AAA GAA CAG 
HJV 5562 FWD AGC GGG TGC GTA CAT CTT CTC CTC 
HJV 6168 FWD GGC AGC GGC GAC TAA A 
HJV 6316 FWD ACG ACG GAA AAT GTT ACC CAA TAC 
HJV 6946 FWD GCG TGT GCA GCC TTT ATC GGA GAC 
HJV 7444 FWD TTC CTT ATC CGC AAT TGA CTT TTC 
HJV 7817 FWD TGT CGG CGG AAG GCT AAT GAA ACC 
HJV 8388 FWD CAG AAA CGG AGC ATT ACG GAC GAT 
HJV 8513 FWD CGA CGG CAC AAT ACG AAT ACA AGT 
HJV 9007 FWD GAG ATT ACA GCA CCG GCA CAG TTA 
HJV 9673 FWD TGG GCG AAT CAC TTG GAC ACC TCT 
HJV 10221 FWD GTC GGC CTG CAA ATA GTA 
HJV 10734 FWD ACG GTG ACG GCC TGC ATT TAC TCC 
HJV 511 REV CGT GAA CCG CAT ATA CAT CTT G 
HJV 1305 REV AGC CCA GCA GCA GCC CAT TGT AAG 
HJV 1824 REV GTA TCT GCC TGC CCT CCC CTT GTG 
HJV 2279 REV TCT TTC TTG GCG CTG ACG ACG AG 
HJV 2902 REV TTC GTT TTT CAG TGC GGG TTA GC 
HJV 3605 REV GAT GGC CCT ATT GAT TCC 
HJV 4282 REV CCG CCA ATT TTG TGT CCC CTT CTG 
HJV 4615 REV CCT TGC CTT CGG TAA CTG A 
HJV 5405 REV CTA GGC GCA GGT ATC GGT TTA T 
HJV 5983 REV TAG CGA CGG TGG GAT AGT TTT 
HJV 6523 REV GCG GGT CGG CTG CTT GAA 
HJV 7364 REV CGC TTA AAG TTC TTC ACG CTA TCT 
HJV 7672 REV GTG GCC TTC GGT TTC GGT TGA GT 
HJV 8150 REV CAG AGC CGT CCT TGA GCC TTC GTT 
HJV 8805 REV TGC CGA CGA ACT TCC TCC TTA TCT 
HJV 9487 REV GGA TGC CGA TGG TAG TAA TGT A 
HJV 10105 REV GCG CCT CCC CAC ATA AAT  
HJV 10771 REV CCA CCA AAA TCG GCG GAG TAA A 




Primers were designed using the DNASTAR Lasergene 9 Primer Select Program 
(DNASTAR, Madison, WI).  To create the primers used to sequence complete genomes, a 
consensus of the only three published HJV whole genome sequences- strains 585-01, 744-01, 
and B230 (Accession #: FJ827631.1, GU167952.1, GQ227789)- was used.  Primers were 
ordered from the CDC Division of Scientific Resources’ Biotechnology Core Facility (CDC, 
Atlanta, GA).  Primer stocks were reconstituted in RNAse/DNAse free sterile water (Life 
Technologies) to a concentration of 200 µM.  Master stocks were held at -70°C.  Individual 
working stock aliquots were created by diluting master stocks to 25 µM with RNAse/DNAse free 
sterile water and stored at -20°C.  Primer sequences are listed in Table 8. 
 
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
RT-PCR was performed in GeneMate 0.2 mL high performance PCR tubes (Bioexpress, 
Kaysville, UT) using a Qiagen One-step RT-PCR Kit on a DNA Engine Peltier Thermal Cycler 
(MJ Research, Waltham, MA) and following the recommended cycling parameters included with 
the kit (Table 9).  Amplified reactions were held at 4°C for less than 24 hours and then were 
loaded onto a previously prepared 1% agarose gel.  A 1kb deoxyribonucleic acid (DNA) ladder 
was used to estimate PCR fragment size (Promega, Madison, WI), by running samples at 100V 
for approximately one hour.  Bands were visualized and photographed using the Gel Logic 200 
Gel Imaging System (Kodak, Rochester, NY).  Bands of the correct size were cut out of the gels 
using a clean scalpel and were placed in individual 1.7 mL tubes.  The tubes were weighed and 




Table 9: Thermocycling conditions for RT-PCR 
Step Temperature Time 
1 50°C 30 min 
2 95°C 15 min 
3 94°C 10 sec 
4 50°C 30 sec 
5 72°C 3 min 
6                                      go to step 3 30x 
7 72°C 10 min 
8 4°C 24 hours 
 
DNA was isolated from the gel fragment using a QIAquick Gel Extraction Kit (Qiagen) 
according to the manufacturer’s protocol.  After extraction, samples were quantified using the 
Qubit dsDNA BR assay (Life Technologies). 
 
5’ RACE 
To obtain the complete 5’ nucleotide sequence, amplification of the 5’ region was 
performed using the First Choice RLM-RACE Kit (Ambion) following the 5’ RLM-RACE 
Protocol provided with the kit and using the standard reaction volumes. 
 
Sequencing 
Cleaned and quantified PCR product was used for Sanger sequencing using BigDye 
Terminator v3.1 Cycle Sequencing kits (Life Technologies).  Samples were prepared in 0.5 mL 
thin-walled PCR tubes.  A total of 20 ng of DNA in a volume not to exceed 11 µL was used for 
each reaction.  8 µL of Terminator Ready Reaction Mix (1:8 dilution) was combined with 1 µL 
of 25 µM primer.  The reaction volume was brought to 20 µL total using RNase/DNase-free 
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water.  Once the samples were thoroughly mixed, they were placed in a thermocycler and 
subjected to the conditions listed in Table 10. 
 
Table 10: Thermocycling Conditions for Big Dye Reactions 
Time Temperature Repeat 
1 minute 96°C 1x 
15 seconds 96°C 
25x 10 seconds 50°C 
2-4 minutes 60°C 
forever 4°C 1x 
 
Samples were cleaned using a BigDye Xterminator Purification Kit and run on an 3130xl 
Genetic Analyzer sequencer (Applied Biosystems).  Sequencing raw chromatograms were 
analyzed using Lasergene DNAStar SeqMan (DNASTAR, Madison, WI).  Sequences were 




Using the Molecular Evolution Genetic Analysis (MEGA) version 5 program, alignments 
of entire nucleotide sequences of HJV were made.  A second tree was created using WEEV 
Imperial sequences as an out group.  The HJV sequences used were those obtained in the 
sequencing portion of this work and whole HJV sequences available on GenBank. The WEEV 
Imperial sequence was obtained previously by the Alphavirus Laboratory.   
After alignment by the Clustal W method, the Maximum Likelihood statistical method 
was used to formulate the phylogenetic tree.  The tree was created using the Bootstrap Method as 
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the Test of Phylogeny with 500 replications.  The calculations employed the Tamura-Nei model 
for nucleotide substitutions.  The ML Heuristic method used was the Nearest-Neighbor 
Interchange (NNI). 
  
Results and Discussion 
To begin the work of understanding HJV in relation to its nearest neighbors, WEEV and 
EEEV, the initial work focused on the genetics of HJV.  A NLM/NCBI Nucleotide (GenBank) 
search for “Highlands J Virus” yielded 32 total entries, but only three complete genome 
sequences (strains B230, 585-01, and 744-01).  This lack of available genetic information 
necessitated the sequencing of additional HJV genomes for comparison.  A consensus sequence 
was created using the three complete genomes available in GenBank and primers were designed 
using the consensus sequence.  Seven strains of HJV were chosen from the fourteen available at 
the CDC for full genomic sequencing. Those chosen were selected to represent various locations, 
years of isolation, and isolation sources to increase the maximum likelihood of viral diversity.   
Most available literature has focused on strain B230, so this strain was chosen as the 
strain to which all others would be compared.  Interestingly, two potential differences (“wobble 
bases”) and 1 nucleotide difference were found in the sequence of B230 obtained in this study as 
compared with the published B230 genome (GenBank Accession #GQ227789).  Both uncertain 
loci were mixed nucleotide populations located in the E3 gene, at genome nucleotide positions 
8301 and 8313 in the newly sequenced B230. The difference at 8301 was a Y (C or T) at the first 
position of the codon resulting in a potential change from the Arg in the GenBank sequence to a 
cysteine (Cys) in the current sequence.  This switch would constitute a basic to non-polar shift in 
amino acid type classification.  The uncertainty at nucleotide 8313 was an R (A or G) at the first 
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position of the codon resulting in the presence of either a methionine (Met) or a valine (Val) 
residue in the current sequence. Both Met and Val are non-polar residues, meaning the charge on 
the amino acid is conservative.  For the purpose of comparison, the amino acids associated with 
nucleotide positions 8301 and 8313 are listed as Arg and Val, which are common to all of the 
strains sequenced in this project.   
One certain nucleotide difference between the GenBank B230 strain and the B230 
genome sequenced for this study occurred at genome nucleotide position 8605 and was 
characterized by a simple transition from A to G.  This resulted in a shift from the Glu (common 
to most other strains and present in the GenBank B230) to Gly (present in the current B230) 
which causes a shift from acidic to non-polar residues.  Interestingly, this difference is present in 
strain 64A-1519, but in no other sequences examined.   For the purpose of comparison, the Gly 
in the B230 sequence obtained in this work was used since this is the strain available for future 
studies.  The sequence differences noted here were likely due to differences in passage histories. 
Strain 64A-1519 is genetically most similar to B230 with 22 nucleotide differences, only 
five of which resulted in a change in amino acid residues.  Strain WX3-2AP was the most 
divergent from B230 with a total of 167 nucleotide substitutions spread over the entire genome.  
Despite this large number of nucleotide differences, there were a great number of nucleotide 
mutations in which the amino acid was conserved (synonymous mutations); only eight changes 
resulted in amino acid differences in comparison with strain B230.  The number of nucleotide 
and amino acid substitutions between strains of HJV are summarized in Table 11, and percent 
nucleotide and amino acid identity are shown in Table 12.  Although there appear to be a large 
number of nucleotide substitutions, especially in WX3-2AP, the number of amino acid changes 
is limited since the vast majority of nucleotide substitutions were synonymous changes.   
	  33	  
Table 11: Number of nucleotide and amino acid differences between strains of HJV 
















B230   5 10 6 9 8 8 
64A-1519 22   7 3 6 5 11 
AB-80-9 45 43   6 1 6 14 
W17791 36 32 55   5 4 10 
RU-M-80-259 52 49 14 59   5 13 
73V-2540 46 40 31 55 35   12 
WX3-2AP 167 184 204 198 212 207   
	  
number of nucleotide changes 
 
Table 12: Percent identity by nucleotide and amino acid for HJV strains 















B230   99.86 99.73 99.84 99.84 99.78 99.78 
64A-1519 99.81   99.81 99.92 99.84 99.86 99.70 
AB-80-9 99.61 99.63   99.84 99.97 99.84 99.62 
W17791 99.67 99.72 99.52   99.86 99.89 99.73 
RU-M-80-259 99.55 99.57 99.88 99.49   99.86 99.65 
73V-2540 99.60 99.65 99.73 99.52 99.70   99.67 
WX3-2AP 98.55 98.40 99.23 99.28 98.16 98.20   
	  
Percent Identity, nucleotide 
 
The 20 total amino acid substitutions between B230 and the other strains are located in 
nearly every gene, but the majority are located in nonstructural genes nsP2 and nsP3 with 6 
mutations each, respectively.  The nsP1 and E1 genes had only one substitution each while nsP4, 
C, and E2 had 2 substitutions each.  Of the 20 total substitutions, 13 involved a change that 
retained the overall characteristics of the amino acid. For example, a polar amino acid was 
replaced with another polar amino acid.  All of the nsP3 and E1 changes, and some of those in 
the nsP2, C and E2 genes, exhibited this type of shift.  Seven substitutions involved a change in 
charge or classification of the amino acid. For example, a basic amino acid was replaced with a 
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polar amino acid.  All of the mutations in nsP1 and nsP4, and some of the changes in nsP2, C, 
and E2, exhibited this type of change.  
There were a number of amino acid substitutions common to multiple strains when 
compared with B230.  A Met to lysine (Lys) mutation at genome nucleotide position 3569, 
located in the nsP2 gene, was present in all strains except for B230 and WX3-2AP.  The same 
applies to a phenylalanine (Phe) to leucine (Leu) mutation at genome nucleotide 5122, located in 
nsP3, and an Asn to Ile difference at nucleotide 5813, located in nsP4.  A single mutation at 
genome nucleotide 9243 resulted in an Ile in all strains except for B230, which possesses a Val.  
Although they differed by a number of synonymous nucleotide changes, strains AB-80-9 and 
RU-M-259 had only one non-synonymous residue substitution between them: a single difference 
in the E1 gene at genome nucleotide 10123.  This is not unexpected since they were both isolated 
from New Jersey in 1980 and, therefore, were likely to be quite similar.  WX3-2AP had the 
largest number of unique mutations, sharing only two of its eight mutations with the other 
strains.  A summary of the amino acid differences can be found in Table 13.  Changes 
highlighted in yellow did not result in a change in characteristic of the amino acid, while those 
highlighted in red resulted in a change of characteristic of the amino acid.  Those cells in black 
indicate that the amino acid for that strain is the same as that for strain B230. 
Once the genomes were completely individually analyzed, sequences were imported into 
MEGA5 for alignment and phylogenetic analysis.  The seven strains sequenced in their entirety 
were used along with those HJV strains from GenBank and WEEV Imperial strain.  A 
phylogenetic tree was created from the selected strains.  Strains B230 and 64A-1519 occupy a 
small branch of the tree that comprises Lineage 1.  RU-M80-259 and AB-80-9 also occupy their 
own branch, but are paired with 73V-2540, and these strains comprise Lineage 2.  The Lineage 3 
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Table 13: Amino acid differences between strain B230 and all other strains examined 
	   	   	  
Amino Acid   
	   	   	  












2540 W17791 WX3- 2AP Result 
nsP1 273 228 HIS           GLN BASIC -> POLAR 
nsP2 1873 229 ILE VAL           NON-POLAR -> NON-POLAR 
nsP2 1879 235 ILE           VAL NON-POLAR -> NON-POLAR 
nsP2 2322 678 GLN           HIS POLAR -> BASIC 
nsP2 3158 1514 ARG           LYS BASIC -> BASIC 
nsP2 3569 1925 MET LYS LYS LYS LYS LYS   NON-POLAR -> BASIC 
nsP2 3893 2249 SER   ASN ASN       POLAR -> POLAR 
nsP3 4316 290 ALA   VAL VAL       NON-POLAR -> NON-POLAR 
nsP3 4942 916 SER       GLY     POLAR -> NON-POLAR 
nsP3 4951 925 VAL           ILE NON-POLAR -> NON-POLAR 
nsP3 5000 974 ALA         VAL   NON-POLAR -> NON-POLAR 
nsP3 5122 1096 PHE LEU LEU LEU LEU LEU   NON-POLAR -> NON-POLAR 
nsP3 5470 1444 ILE       VAL     NON-POLAR -> NON-POLAR 
nsP4 5813 242 ASN ILE ILE ILE ILE ILE   POLAR -> NON-POLAR 
nsP4 5814 243 ASN   ILE ILE ILE     POLAR -> NON-POLAR 
C 7612 173 PRO   LEU LEU       NON-POLAR -> NON-POLAR 
C 7719 280 PRO           SER NON-POLAR -> POLAR 
E2 8605 209 GLY   GLU GLU GLU GLU GLU NON-POLAR -> ACIDIC 
E2 9243 847 VAL ILE ILE ILE ILE ILE ILE NON-POLAR -> NON-POLAR 
E1 10123 293 SER   ASN         POLAR -> POLAR 
 
branch includes strains 744-01, 585-01, and W17791, and these strains appear to be very closely 
related to Lineage 2 by number and locations of amino acid differences, particularly strain 73V-
2540.  Interestingly, if the GenBank strains are not included in the phylogram, W17791 pairs 
most closely with Lineage 1 strains, however bootstrapping indicates that the grouping is 
tenuous.  WX3-2AP is an outlier compared to the rest of the HJV strains, occupying its own 
branch of the tree as Lineage 4.  When WEEV is added as an out-group, the configuration of the 
tree does not change. However, the small degree of genetic variability within the HJV strains is 
more apparent.  The phylogenetic tree is listed in Figures 6 (HJV tree with WEEV out-group) 
and 7 (HJV tree without out-group). 
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Figure 6: Maximum Likelihood Tree for HJV (with WEEV outgroup included) 
 
 
Figure 7: Maximum Likelihood Tree for HJV 
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 While HJV is widely presumed to be maintained by Cs. melanura, the true vector 
capacity of other species, including Cx. tarsalis, is unknown for HJV.  Due to the fact that HJV 
has never been isolated in the western portions of the US, it is assumed that Cx. tarsalis is not a 
competent vector of HJV. Given the close genetic relationship between WEEV and HJV, 
infectious studies were clearly warranted.  A number of differences between HJV strains were 
found in the genetic studies performed in this project and the identification of four distinct 
lineages led to interesting possibilities for mosquito infection differences between lineages and 
strains.   
 
Materials and Methods 
Rearing Culex tarsalis 
To maintain the mosquito colony, adult female Cx. tarsalis from Kern National Wildlife 
Refuge (strain KNWR) were fed using Hemotek artificial feeders (Hemotek, England) and 4-5 
mL of goose blood (Colorado Serum Company, Denver, CO) on Fridays (Day 1).  Hemotek 
feeding arms heated the blood to 37°C and mosquitoes were allowed to feed for one hour. 
Typical feed rates were around 70% using this procedure.   
On Sundays (Day 3), 16 oz. Solo cups (Dart, Madison, WI) with tap water were placed 
into the cage to allow females to lay eggs.  The cups were removed on Mondays (Day 4), and the 
deposited egg rafts were hatched in shallow plastic pans with tap water.  Between 5 and 10 rafts 
were placed in each pan with a small amount of Colton Culex Diet (CCD).  CCD is a mixture of 
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11.45g finely ground fish food, 15.06g liver powder (MP Biomedicals, Santa Ana, CA) and 1.25 
Brain/Heart Infusion Broth, Modified (Becton Dickinson, Franklin Lakes, NJ). The eggs 
typically hatched within 24-48 hours. 
On Tuesdays (Day 5), pans were checked for hatching, and the larvae were fed CCD if 
needed.  On Wednesdays (Day 6), the final density of larvae in the pans was adjusted to around 
250 larvae per pan.  
Depending on the instar of the larvae on Thursdays (Day 7), the larvae were fed either 
CCD or finely ground fish food.  After they reached the second instar, CCD was no longer used 
because the particles were too small and the larvae would have required excessive quantities of 
CCD to sustain them, resulting in the development of biofilm on the surface of the water. Pans 
were fed crushed fish food on Fridays (Day 8), Sundays (Day 10), and Mondays (Day 11).  
On Tuesdays (Day 12), the first pupations occurred. On Thursdays (Day 14) a high 
percentage of the pupae were female and these were placed in a water-filled cup in new adult 
mosquito cages (Bioquip, Rancho Dominguez, CA) equipped to ensure that mosquitoes could 
not escape from any crevices in the cages.  A small jar was filled with a solution of 5% sucrose 
and a gauze pad was secured across the top of the jar with a rubber band. This solution was 
placed (inverted) on top of the cage so that the mosquitoes could access it for sustenance.   
On Fridays (Day 15), the last of the pupae were collected and were placed into the cage 
as described above. Mosquitoes emerging on this day would be 3 days old for an infectious 
blood meal on Mondays (Day 18).  On Saturday mornings (Day 16), both pupation cups were 
removed from the cages to ensure that the mosquitoes that emerged were either 3 or 4 days old 
for the subsequent feed.   
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Infectious Blood Meal Preparations 
In preparation for infections blood feeds, gallon-sized waxed paper cartons (Huhtamaki, 
De Soto, KS) were prepared with fine-mesh nylon tulle lids to allow secure and unimpaired 
feeding. Approximately 250 female Cx. tarsalis were placed in a gallon container for each virus 
used in the infectious feed.  Approximately 50 female Cx. tarsalis were used for the negative 
control feed.  The mosquitoes were denied sucrose solution overnight in order to ensure that they 
would feed the following morning. 
 Pint-size waxed paper containers (Huhtamaki) were prepared for blood-fed female 
mosquitoes post-feed.  Five of these cartons were created for each virus used in the feed: 1 for 
day 4, 2 for day 8, and 2 for day 11.  A single carton was created for the negative control 
mosquitoes. 
 
Infectious Bloodmeal Protocol 
 For each virus used in the feed, 0.1g of sucrose was dissolved in 1 mL of FBS in a 15 mL 
conical centrifuge tube (Corning). A 30 mL aliquot of goose blood (Colorado Serum Company) 
was poured into a 50 mL conical centrifuge tube (Corning) and the volume brought to 50 mL 
with DPBS (Gibco).  The blood was inverted to mix and then centrifuged in a spin bucket rotor 
at 2205 x g for 10 minutes.  Once the blood was spun down, the light colored/clear top layer was 
poured from the tube.  The volume was brought again to 50 mL with DPBS to wash the red 
blood cells. The spin/wash procedure was repeated 3-5 more times until the volume of the 
compacted red blood cells was approximately 10 mL. 
 Previously titrated virus stocks were used to prepare dilutions for the infectious blood 
meal.  The volume of virus used in the feeds was calculated by using C1V1 = C2V2 and using 
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approximately 5.5 logs of virus as the final concentration in 3 mL of total blood feed volume.  
The final proportions of blood, virus, and sucrose were 1:1:1.  Complete media without virus was 
used for the negative feed control.   For each meal, 1 mL of red blood cells, 1 mL of sucrose 
mixture, and 1 mL of diluted virus (or negative control media) were mixed in a 15 mL conical 
centrifuge tube to create a final volume of 3 mL.  
 Feeding units were prepared by placing Hemotek membrane over the feeders and 
securing it using O-rings.  A 200 µL aliquot of each virus and the negative control were removed 
for use in back-titrations of the meals.  Using a transfer pipette (Fisher Scientific), 3 mL of 
prepared blood were carefully loaded into each feeder.  As soon as all of the feeders were loaded, 
they were attached to Hemotek feeding arms calibrated to 37°C and placed on the mesh top of 
the gallon containers.  The back titer tubes were immediately placed in a water bath at 37°C to 
mimic the conditions of the feeders. 
The mosquitoes were allowed to feed on the prepared blood meals for approximately 1 
hour, after which time the feeders were removed from the cages and the back-titer tubes were 
removed from the water bath and placed in the freezer at -70°C for later titration by plaque assay.  
To separate fully engorged females from females that partially fed or did not feed at all, 
individual cartons were placed one at a time at 4°C until the mosquitoes were unresponsive.  
Working in a secure glove box, the mosquitoes were poured from the carton onto a glass petri 
dish sitting on ice. Using forceps, the engorged females were separated from those that did not 
feed.  Twenty-five engorged females were placed into each of the four pint cartons for 
processing on days 8 and 11. An additional 40 females were placed into the single carton for day 
4 processing. The cartons were labeled and placed into a 12” x 12” mosquito cage (Bioquip) for 
secondary containment.  This cage was then placed into an environmental chamber set at 28°C 
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for incubation until they were processed. The negative control consisted of 1 carton containing 
25 females for processing on day 11.  All remaining mosquitoes in the petri dishes were flooded 
with 70% ethanol and were discarded. 
 
Processing Mosquitoes 
 Blood-fed mosquitoes were processed on days 4, 8, and 11 post infectious feed. Working 
with one container at a time, the number of dead mosquitoes on the bottom of the carton was 
counted and recorded.  The pint cartons were placed in the refrigerator until the mosquitoes were 
unresponsive.  They were then transferred to the freezer for approximately 1 minute until they 
were completely still.  The carton was then transferred to the glove box where the dead 
mosquitoes were separated and counted, and live but anesthetized females were further 
processed. 
 Mosquitoes were individually transferred to an ethanol-washed glass microscope slide.  
Their heads were separated from their bodies using a scalpel blade.  Each head was placed into a 
1.7 mL tube labeled “H#” and the corresponding body was placed in a 1.7 mL tube labeled “B#.”  
The scalpel blade was then dipped into the 70% ethanol solution and dried carefully using a 
wipe.  The tubes containing the heads and bodies were held on ice until processing was 
completed.   Upon completion, all samples were stored at -70°C.  This procedure was repeated 
for the processing of each virus or negative control on the designated day.  
 
Mosquito Grinding 
 Gasketed cryovials were labeled with the head and body numbers, virus, replicate, and 
date of the feed.  A 400 µL aliquot of mosquito tissue culture media was drawn up into an ART 
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1000 pipette tip, approximately half of which was added to the tube containing the head or body 
sample.  Using a microfuge pestle (Kontes/Kimble Chase, Vineland, NJ), the sample was ground 
against the side of the tube.  The pestle was rinsed using the remainder of the media in the pipette 
tip. The ground sample was then drawn into a 1 mL needle-less syringe (Becton Dickinson), 
after which a 0.2 µM nylon Acrodisc 13mm syringe tip filter (Pall, Port Washington, NY) was 
secured to the tip of the syringe.  The sample was passed through the filter by depressing the 




 Cell-culture-treated 96-well plates were labeled, and 100 µL of each sample was added to 
an individual well of the 96-well plate.  Six wells were reserved for control samples: 2 negative 
control mosquitoes (NH1, NH2, NB1, NB2) and a cell-only culture control (-).  To the cell 
culture-only control wells, 100 µL of mosquito media was added as a placeholder to ensure equal 
volume in all wells.  Plate maps were created to easily track individual samples across a plate, as 
shown in Figure 8.   
 
Figure 8: CPE Plate Map 
 
          A1     2        3         4        5         6        7         8         9       10       11       12 
 
                               B 
 
                              C 
 
        D 
 
                              E 
 
        F 
 
        G 
 
                              H 
                               
 
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 
H13 H14 
B1 
H15 H16 H17 H18 H19 H20 H21 H22 H23 H24 
































































































































































One 150 cm2 flask with a confluent layer of Vero cells was used for each group of 5 96-
well plates processed.  Once all of the samples were loaded into the wells of the plates, the flask 
of confluent Vero cells was rinsed three times with DPBS and then trypsinized using 5 mL 
0.05% Trypsin EDTA (Gibco).  The cells were then re-suspended in 5 mL mosquito medium 
ensuring that cells were uniformly single.  An additional 20 mL of mosquito media was added to 
bring the volume to 25 mL.  The cell suspension was transferred to a sterile solution basin 
(Heathrow Scientific), and a multi-channel pipettor was used to add 50 µL of cell suspension to 
each well. Virus attachment to cells occurred as the cells settled to the bottom and adhered.  
Plates were transferred to Tupperware storage boxes with a single damp paper towel to ensure 
that the plates did not dry out.  The plates were incubated at 37°C with 5% CO2 and were 
checked daily for 4 days for CPE.   
 Due to the fact that alphaviruses grow quickly in culture, CPE was often observed as 
early as day 2, but cells were checked daily and final scores were read on day 4.  If cells were 
beginning to ball up and detach, usually in small plaque-like patches, the appropriate well on the 
plate maps were marked with a “+/-.”  Only once cells were completely detached and dead, plate 
maps were marked with a “+.”  
 Infection and dissemination rates were calculated using the day 4 “+” markings. The 
percent infected was calculated as: (number of CPE-positive bodies / total number of bodies 
processed) x 100.  Dissemination rates were calculated using the number of CPE positive heads.  
The percent disseminated was calculated as: (number of CPE positive heads / total number of 
heads processed) x 100.  Percent disseminated of those infected rates were calculated as: 
(number of CPE-positive heads / number of CPE-positive bodies) x 100.   
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Mosquito Saliva Collection 
Mosquitoes were blood-fed approximately 5.5 log10 of infectious HJV strain AB-80-9 per 
the “Infectious Bloodmeal Protocol.” A 5 µL aliquot of Type B Immersion Oil (Cargill, Cedar 
Grove, NJ) was loaded into the end of glass capillary tubes (Chase Scientific Glass, Rockwood, 
TN).  The opposite end was plugged using critoseal putty (McCormick Scientific, St. Louis, MO) 
so that the oil was flush with the top of the tube. Additional critoseal putty was added to the 
bottom if the oil level dropped over time.   
Mosquito cartons were briefly placed in the freezer to render all mosquitoes unconscious.  
Once their legs ceased moving, the mosquitoes were placed in a glass petri dish and held on ice.  
The legs and wings of each mosquito were removed.  Using metal forceps on the wing stubs or 
the extreme end of the abdomen, the mosquito was lifted to place the proboscis of the mosquito 
into the oil in the capillary tube.  Mosquitoes were watched closely for any movement indicating 
salivation, and were allowed to salivate into the oil for 60 minutes.   
At the end of the hour-long salivation period, the mosquitoes were removed from the 
capillary tubes and processed following the previously described “Processing Mosquitoes” 
protocol.  Separated heads and bodies were stored at -80°C until ground and filtered.  The oil-
filled end of the capillary tube was broken off into a 1.7 mL tube with 450 µL of mosquito 
media.  The tubes were centrifuged at 4500 x g for 5 minutes. They were then stored at -80°C 
until RNA extraction was performed. 
 
qRT-PCR 
One-step quantitative real time RT-PCR (qRT-PCR) was performed to determine titers of 
virus in the heads, bodies, and saliva of the mosquitoes and to confirm the results of the CPE 
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tests.  Primers and a probe were designed using Primer Select in the 6K region of HJV. This 
region was chosen because the best primers Primer Select identified that would successfully bind 
to the most strains as compared to other sets were in this region.  The HJV 9838 probe was 
designed with a 5’-FAM reporter dye and 3’-TAMRA quencher.  Primers were diluted to 40 µM 
and the probes were diluted to 25 µM in RNase/DNase free sterile water.  
 
Table 14: Primers and Probe for qRT-PCR Assay 
HJV Primer Name  
(location in HJV genome) Primer Sequence (5' to 3') 
HJV 9741 FWD 5’ ACT TGC CGC ACT TAT CAT CCT GTT 3’ 
HJV 9866 REV 5’ CCA CTA GCG CTT TAT ACG GGA CTC 3’ 
HJV 9838 probe 5’ CAT GCG ACC ACT GTG CCA AAT GTT CC 3’ 
  
 Ten CPE-positive and 2 CPE-negative head and body pairs were chosen from each 
mosquito feed using a random number generator (www.random.org).  RNA was extracted from 
the chosen samples using the QiaAmp Viral RNA Mini Kit (Qiagen) from 100 µL of mosquito 
head or body filtrate. Negative extraction controls were included using mosquito media.  The 
Purification of Viral RNA (Spin Protocol) was followed, except the samples were eluted in 100 
µL of buffer AVE rather than the protocol-specified 60 µL.  The eluted samples were then stored 
at -20°C. 
A standard curve was generated to correlate RNA copies with virus titer as described by 
Linnen et al. [85].  A 10-fold serial dilution series of virus stock was made by adding 50 µL of 
virus to 450 µL of complete media.  A series of 10-1 to 10-6 dilutions was created.  A plaque 
assay was performed on each dilution in the series and titers were calculated.  RNA was 
extracted from each of the dilutions in the series and the calculated titer values were then 
associated with the RNA copies as the standard curve. 
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A qRT-PCR reaction was performed in duplicate using a protocol based on the Qiagen 
Quantitect probe (TaqMan) RT-PCR kit and the cycling conditions in Table 15. The reactions 
were performed in 96-well qRT-PCR plates (BioRad, Hercules, CA) with a total reaction volume 
of 50 µL using an iQ5 real-time detection system (Bio-Rad, Hercules, CA).  For each plate run, a 
“no reverse transcriptase” and a “no template” control were included to ensure that there was no 
RNA contamination present in the reagents. The Quantitect probe RT-PCR kit (Qiagen) reagents 
were used for the reactions. 
 
Table 15: Thermocycling conditions for qRT-PCR Assay 
Step Temperature Time 
1 50°C 30 minutes 
2 95°C 15 minutes 
3 94°C 15 seconds 
4 60°C 1 minute 
6                                            go to step 3 45x 
7   End 
 
Upon completion of the program, the amplification curves and threshold line were 
adjusted to a predetermined value of 200 to ensure comparability between runs.  A PCR 
efficiency plot between 90% and 100% was optimal for this assay and if the efficiency was than 
90%, the removal of the 10-6 standard from the equation brought efficiency into range.  The “no 
reverse transcriptase” and “no template” controls were checked to ensure that they indicated no 
amplification.  The cutoff Ct level was pre-determined to be 39. Because the samples were run in 
duplicate, the Ct values were checked to ensure that the difference was no greater than 0.5 Ct 
units between the two replicates.  A difference of greater than 0.5 would indicate unequal 
volume of sample dispensed in the two wells.  Any samples with a Ct difference of greater than 
0.5 were retested. Average titer in plaque-forming unit (pfu) equivalents were calculated by 
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multiplying the value retrieved from qRT-PCR and multiplying it by the dilution factors used to 
generate the sample.  These were expressed in pfu equivalents/body, pfu equivalents/head, and 
pfu equivalents/saliva.  
For each blood feed and time point, averages were taken for both the heads and bodies 
from those that were qRT-PCR positive.   In order to get a summary number, averages were also 
taken for each time point for both heads and bodies using the averages found for the two blood 
feeds, generating one number for each virus at each time point for heads or bodies. 
 
Statistics 
Statistical analysis was performed on all mosquito blood feed data using freely available 
tools to determine if infection and dissemination rates were statistically significant 
(https://vassarstats.net/odds2x2.html).  Pearson Chi-square and p-value statistics were calculated 
using 2x2 Contingency Tables.  Fisher Exact Probability Tests (2-tailed P-value) were also 
calculated using this software.   
 
Results and Discussion 
Mosquito Infections with HJV 
In order to compare the in vivo phenotypic characteristics associated with the genetic 
differences between the HJV strains, two genetically disparate strains were chosen for initial 
mosquito infection experiments with the assumption that if they showed similar infection and 
dissemination rates that most strains of HJV were likely similar in infection patterns.  Cx. 
tarsalis mosquitoes were offered blood meals prepared with known concentrations of virus, and 
back titers were performed to confirm the titer of the virus in the bloodmeal as described in 
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“Materials and Methods.”  Infections were performed in duplicate on different dates with 
different mosquito hatches to ensure reproducibility.  Strains B230 and WX3-2AP were chosen 
as the primary strains due to the large number of genetic differences and because as the prototype 
strain, B230 is the strain most reported in scientific literature.  Data from a recent test of the 
Imperial strain of WEEV was also included to serve as a comparison for Cx. tarsalis infection. 
Cx. tarsalis were infected on day 0 and collected at 4, 8 and 11 days post infection (dpi), 
when they were processed according to the procedure listed in “Materials and Methods.” An 
infected mosquito body indicated a midgut infection while an infected head indicated a 
disseminated infection and the potential for transmission.  Although the salivary glands are not 
located in the head of the mosquito, an infection of the mosquito hemolymph circulating through 
the head indicates the potential for infection of all mosquito organs, including the salivary 
glands.  In order to determine if a salivary gland barrier existed, one strain of HJV was selected 
for transmission experiments. 
Statistical analyses were performed to evaluate differences between the data for blood 
feeds 1 and 2 for each virus, as well as the differences between infection, dissemination and 
transmission rates.  Chi-square two-way tests of independence were performed and the p-value 
was found for each data comparison.  P-values of ≤.05 were considered significant, while values 
≤.01 were considered highly significant. 
The data for the two blood feeds was combined into a single dataset, and the differences 
between this combined dataset and the two original datasets was statistically evaluated as 
previously described.  Pearson p values for averaged datasets, when compared to their separated 
sets, were between 0.17 and 1.00, indicating that there were no statistically significant 
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differences.  The separate datasets are listed in Appendix A, but the combined datasets shown 
here (Table 16) will be used for the comparative analyses.  
 






feed # Tested 
# 
Infected # Diss 
% 




HJV B230 Combined Data 
4 78 31 21 39.7 26.9 67.7 
Lineage 
1 8 83 26 22 31.3 26.5 84.6 





4 75 23 15 30.7 20.0 65.2 
Lineage 
1 8 80 18 17 22.5 21.3 94.4 





4 73 53 25 72.6 34.2 47.2 
Lineage 
4 8 84 59 52 70.2 61.9 88.1 
11 65 51 46 78.5 70.8 90.2 
HJV AB-80-9 Combined Data 
4 75 63 28 84.0 37.3 44.4 
Lineage 
2 8 80 67 54 83.8 67.5 80.6 




Data 8 57 46 29 80.7 50.9 63.0   
# Diss- Number of mosquitoes with disseminated infection; % Diss- % Disseminated of the total tested; %Diss of infected- % 
Disseminated of those mosquitoes infected 
 
Strain B230 infection and dissemination rates were significantly lower than the rates 
shown by WEEV Imperial strain, which infects approximately 80% of Cx. tarsalis.  Infection 
rates for B230 ranged from 39.7% at 4 dpi to 27.6% at 11 dpi, while dissemination rates 
decreased from 26.9% at 4 dpi to 21.1% at 11 dpi (Figures 9 and 10). These results are unusual 
because it is expected that higher infection and dissemination rates would occur at later time 
points due to the fact that the virus has a longer period of time to establish midgut infection and, 
from there, to escape from the midgut to establish a disseminated infection.  However, when the 
percentage of infected mosquitoes with a disseminated infection was examined, the 
dissemination rate was found to remain fairly steady between 67.7% and 84.6%, indicating that 
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once B230 was able to infect the mosquito midgut, the virus was able to escape to establish a 
disseminated infection in a predictable percentage of mosquitoes. 
Figure 9: Percent infection, HJV B230 and WX3-2AP 
 
In contrast, strain WX3-2AP exhibited very high infection and dissemination rates, equal 
to those rates previously published for many WEEV strains.  Strain WX3-2AP infection rates 
increased from 72.6% at 4 dpi to 78.5% at 11 dpi and dissemination rates likewise increased 
from 34.2% at 4 dpi to 70.8% at 11 dpi (Figures 9 and 10).  The percentage of infected 
mosquitoes with dissemination also increased from 47.2% to 90.2% over the course of the study. 
There is a statistical difference between the two strains in their ability to infect and then escape 
the midgut (8 dpi bodies and heads: p=<.0001). 
It has been widely assumed that HJV has never been isolated on the west coast of the 
United States because no competent mosquito vectors exist for the virus in that region. The 
ability of HJV to be transmitted by Cx. tarsalis has never been reported.  The preliminary results 
of this study clearly indicated that Cx. tarsalis is potentially a competent vector for HJV.  
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additional set of feeds with another strain was performed for clarification.  A Lineage 2 strain, 
AB-80-9, was selected for additional mosquito work. 
 
Figure 10: Percent dissemination, HJV B230 and WX3-2AP 
 
Strain AB-80-9 exhibited a decrease in infection rates from 84.0% at 4 dpi to 73.0% at 11 
dpi, however rates remained well above those of B230.  Dissemination rates (of those tested) 
rose from 37.3% at 4 dpi to 69.8% at 11 dpi (Figure 11).  The percentage of infected mosquitoes 
with a disseminated infection likewise rose from 44.4% at 4 dpi to 95.7% at 11 dpi.  There were 
clear similarities in the high rate of infection and dissemination (of the total tested) between 
WX3-2AP and AB-80-9 (8 dpi bodies and heads: p=.25-.45), and a very clear difference in 
infection between WX3-2AP and B230 (8 dpi bodies and heads: p=<.0001).  This data indicates 
that there is a vector competence-modulating factor in strain B230 and that a high infection and 
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Figure 11: Percent dissemination, three HJV strains 
 
On examination of the genetic data from the amino acid differences that were present 
among the three strains tested, only two could be responsible for the differences noted in these 
experiments (Table 17).  Both amino acid differences are present in the E2 glycoprotein, which 
is responsible for recognition, attachment, and infection of the host cell.  The first was located at 
genome nucleotide position 9243 (E2 glycoprotein amino acid 282) and was a Val or Ile element 
resulting in the maintenance of a non-polar charge at that position.  Because the charge is 
conserved with both amino acids, it is not highly likely to be responsible for the differences in 
infectivity seen in this data.  However, previous research has shown that an alanine (Ala)-to-Val 
change at amino acid position 226 of the E1 glycoprotein, which conserves the non-polar charge, 
was responsible for the ability of CHIKV to infect Ae. albopictus in addition to its more 
established vector, Ae. aegypti, during an outbreak in 2006 [86]. The second difference was 
located at genome nucleotide position 8605 (E2 glycoprotein amino acid 69) and was either a 
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difference in charge of the amino acid, and is more likely to be responsible for a significant 
change in infectivity.  
 

















Location  B230 64A- 1519 AB-80-9 
WX3- 
2AP 
Commonality Between Lineages with 
Mutations? 
nsP1 273 His His His Gln no common amino acid between phenotypes 
nsP2 1873 Ile Val Ile Ile no common amino acid between phenotypes 
nsP2 1879 Ile Ile Ile Val no common amino acid between phenotypes 
nsP2 2322 Gln Gln Gln His no common amino acid between phenotypes 
nsP2 3158 Arg Arg Arg Lys no common amino acid between phenotypes 
nsP2 3569 Met Lys Lys Met no common amino acid between phenotypes 
nsP2 3893 Ser Ser Asn Ser no common amino acid between phenotypes 
nsP3 4316 Ala Ala Val Ala no common amino acid between phenotypes 
nsP3 4951 Val Val Val Ile no common amino acid between phenotypes 
nsP3 5122 Phe Leu Leu Phe no common amino acid between phenotypes 
nsP4 5813 Asn Ile Ile Asn no common amino acid between phenotypes 
nsP4 5814 Asn Asn Ile Asn no common amino acid between phenotypes 
C 7612 Pro Pro Leu Pro no common amino acid between phenotypes 
C 7719 Pro Pro Pro Ser no common amino acid between phenotypes 
E2 8605 Gly Gly Glu Glu COMMONALITY OF AMINO ACID? 
E2 9243 Val Ile Ile Ile COMMONALITY OF AMINO ACID? 
E1 10123 Ser Ser Asn Ser no common amino acid between phenotypes 
 
An additional strain of HJV, strain 64A-1519, was chosen to discern which of the two 
amino acid differences was potentially responsible for the attenuation of B230.  64A-1519 
contains the Gly at nucleotide position 8605, similar to B230, but the Ile at nucleotide position 
9243 common to all other strains of HJV studied here.   Evaluating Cx. tarsalis competence for 
this strain could reveal which of the changes was responsible for the difference in transmission 
phenotype.  If 64A-1519 exhibited poor vector capacity similar to strain B230, then the 8605 (E2 
amino acid 69 Gly) element could be responsible for the attenuation because 64A-1519 and 
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B230 are the only two strains containing the non-polar amino acid.  If, alternatively, 64A-1519 
behaved more similarly to the strains with higher infection and dissemination rates, then the 
9243 nucleotide producing the Ile common to the highly infectious strains could be responsible 
for the difference in phenotype.   
Figure 12: Percent infection, four HJV strains 
 
The 64A-1519 strain exhibited limited vector competence similar to B230 with infection 
rates of 30.7% at 4 dpi stabilizing to 31.3% by 11 dpi (Figure 12).  However, 64A-1519 
exhibited an increase in dissemination (of the total tested) from 20.0% at 4 dpi to 30.0% at 11 dpi 
(Figure 13).  It was curious that the rates did not decrease as they did with strain B230.  Also of 
note was a rise in the percentage of disseminated infections from those infected from 65.2% at 4 
dpi to 96% at 11 dpi.  This indicates that while strain 64A-1519 appears to have difficulty 
infecting the midgut, once it infects the midgut it has no trouble establishing disseminated 
infection.  It should be noted, however, that when comparing B230 with strain 64A-1519, p-
values ranged between 0.20 and 0.62, indicating that the two strains exhibited no statistically 
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Figure 13: Percent dissemination, four HJV Strains 
 
These experiments suggest that the element most likely to be responsible for the poor 
vector infectivity phenotype of the Lineage 1 strains, B230 and 64A-1519, is the 8605 nucleotide 
producing Gly (E2 glycoprotein amino acid 69).  However, the production of a Lineage 1 clone 
and then introduction of the Glu through site directed mutagenesis is necessary to definitively 
prove this amino acid is wholly responsible for the attenuation of Lineage 1 strains in 
comparison with Lineage 2 and 4 strains. 
 
Quantity of Virus in Infected Mosquito Heads and Bodies 
To investigate whether there was a difference in viral titers between the permissive 
Lineage 2 and 4 strains and the less-permissive Lineage 1 strains, ten positive mosquito heads 
and bodies were chosen at random from those that were CPE positive for each feed and time 
point.  Two negative heads and bodies served as negative controls and as validation that the CPE 
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In total, 490 samples were tested by qRT-PCR.  CPE and qRT-PCR results showed high 
concordance, with the exception of 18 samples, or 4%. A total of 13 of these samples consisted 
of heads or bodies that were negative by CPE that were then found positive by qRT-PCR.  This 
was not fully unexpected as qRT-PCR is more sensitive than CPE, and some of the qRT-PCR 
positives had as few as 5 total viral particles in the volume of sample run, which would likely be 
missed by a CPE assay. The other 5 samples were positive by CPE and negative by qRT-PCR.  
This could be due to cross-contamination from formation of HJV aerosols while loading the 
wells of the CPE plates since alphaviruses form aerosols very easily, or again, a very small 
number of viral particles. 
Bodies 
Mosquito bodies tended to have the lowest titer at 4 dpi, an increase to the highest titer at 
8 dpi, with a small, but negligible, drop to the day 11 titer.  B230 bodies, for example, exhibited 
a small increase between the day 4 titer of 6.60 log10 pfu equivalents/body and day 8 titer of 6.87 
log10 pfu equivalents/body, but by day 11 the titer had dropped again slightly to 6.73 log10 pfu 
equivalents/body.  The exception to this trend was strain 64A-1519, which exhibited a very 
similar curve but had the lowest titer at day 11 instead of day 4 (Table 18, Figure 14). 
Lineage 4 strain WX3-2AP bodies reached the highest average titer of any sample for any 
virus tested.  The lowest titer for WX3-2AP was on day 4 at 6.92 log10 pfu equivalents/body.  
The titer then peaked on day 8 at 7.26 log10 pfu equivalents/body.  With the exception of the day 
4 time point for strain 64A-1519 heads and bodies, strain WX3-2AP had the highest titers for 




 Table 18: Average HJV titer for infected bodies 
Virus Part Day post infection Average Titer (log10 pfu equivalents/body) 






















There was no discernable pattern among infected heads in regards to virus titer at each 
time point.  Lineage 1 strain B230 heads had some of the lowest titers, particularly at days 4 and 
8 post infection with titers of 6.03 and 6.05 log10 pfu equivalents/head respectively. At 11 dpi, 



























Table 19: Average HJV titer for infected heads 
Virus Part Day post infection Average Titer (log10 pfu equivalents/head) 
HJV B230 Heads 
D4	   6.03	  
D8	   6.05	  
D11	   6.27	  
HJV AB-80-9 Heads 
D4	   6.32	  
D8	   6.41	  
D11	   6.28	  
HJV WX3-2AP Heads 
D4	   6.43	  
D8	   6.58	  
D11	   6.54	  
HJV 64A-1519 Heads 
D4	   6.80	  
D8	   6.52	  
D11	   6.01	  
 
The other Lineage 1 strain, 64A-1519, exhibited behavior different from all other strains.  
Heads reached their peak titer at day 4 post infection of 6.80 log10 pfu equivalents/head, making 
it the only virus with a titer in the heads of greater than 6.6 log10 pfu equivalents/head.  From the 
day 4 time point, titers dropped to 6.52 log10 pfu equivalents/head on day 8 and 6.01 log10 pfu 
equivalents/head at day 11 (Table 19, Figure 15).  64A-1519 heads and bodies had the largest 
range of titers, having a range of 0.79 log10 pfu equivalents/head and 0.35 log10, pfu 
equivalents/body, while the other viruses exhibited ranges between 0.13 and 0.34 log10 pfu 
equivalents/head or body (data not shown).  However, only 6 and 8 heads were positive from the 
first and second blood feeds, respectively, and the small number of data points could account for 
the different behavior of this strain. 
The highest titer for Lineage 2 strain AB-80-9 was on day 8.  However, the titers 
remained fairly stable at 6.32, 6.41, and 6.28 log10 pfu equivalents/head for days 4, 8 and 11, 
respectively with variability for the entire set of time points of only 0.13 log10 pfu 
equivalents/head (Table 19, Figure 15). 
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Figure 15: Average titers, heads 
 
Lineage 4 strain WX3-2AP heads exhibited a similar curve to the Lineage 2 strain, again 
with stability in titers over time.  The titers for the three time points were 6.43, 6.58, and 6.54 
log10 pfu equivalents/head respectively. With the exception of the day 4 time point for strain 
64A-1519 heads, strain WX3-2AP had the highest titers for heads at all time points (Table 19, 
Figure 15). 
Overall, Lineage 2 and 4 strains exhibited similar titers for both heads and bodies.  This is 
not surprising given the similarity of phenotype within the mosquito.  The Lineage 2 strain 
appears to exhibit slightly lower titers than the Lineage 4 strain.  However, it did not affect the 
infection or dissemination rates for these viruses (Figure 16). 
Despite the difference between the Lineage 1 as compared with the Lineage 2 and 4 
strains in regards to percentage of infectivity and dissemination, the relationship between the 
viruses in terms of titer was less definitive.  While WX3-2AP had the overall highest titers, there 
were time points where the Lineage 1 strains were competitively high, which was unexpected 
































had the highest titer at day 4 of all the viruses, the dissemination rate of 20.0% clearly shows that 
the ability to replicate to a high titer does not necessarily increase the percentage of mosquitoes 
with a disseminated infection.  However, it does show that when the virus is able to establish a 
disseminated infection by escaping the midgut barrier, it is capable of establishing a high titer 
infection and hence may be more likely to be transmitted. 
 
Figure 16: Average titers, Lineage 2 and 4 strains, heads and bodies 
 
Saliva Collection 
 The high infection and dissemination rates in the various strains of HJV do not 
necessarily translate to high vector capacity since there could be a salivary gland escape barrier.  
To test the vector competence for Cx. tarsalis, mosquitoes were infected with HJV AB-80-9, 
chosen due to the high numbers of mosquitoes with disseminated infections.  Mosquito saliva 
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feed # Tested 
# 
Infected # Diss 
% 







Collection 8 49 39 27 79.6 55.1 69.2 
Lineage 
2 
# Diss- Number of Mosquitoes with Disseminated Infection; % Diss- % Disseminated; %Diss of Infected- % Disseminated of 
Those Mosquitoes Infected 
 
A total of 49 mosquitoes imbibed a virus-laden blood meal and, of those, 39 had CPE-
positive bodies and 27 had CPE-positive heads (Table 20).  Of the 49 mosquitoes exposed, 22 
transmitted detectible levels of virus into the oil, meaning 44.9% of all mosquitoes exposed to 
the virus, or 81.5% of those with a disseminated infection (evidenced by CPE-positive heads), 
were able to actively transmit virus (data not shown).  The average titer in the saliva sample was 
5.02 log10 pfu equivalents/saliva, with the highest titer being 5.74 log10 pfu equivalents/saliva 
and the lowest 1.68 log10 pfu equivalents/saliva (Table 21). The dose of HJV required for 
infection of a host is currently unknown, however previous EEEV studies determined that 4.0-
7.0 log10 pfu/mL of virus in Cs. melanura mosquitoes was necessary for transmission [87,88].  
Clearly, Cx. tarsalis mosquitoes are capable of developing salivary titers significantly above 4.0 
log10 in a smaller volume than 1mL so are likely capable of transmitting HJV in a natural setting. 
It is important to note that because the volume of the saliva in the immersion oil was 
impossible to quantify, the number of viral particles is expressed in terms of whole saliva units.  
There exists the potential for significantly higher volumes of virus to be expressed from the 
mosquito host if the volume of saliva expectorated is increased.  Some of the lower titered saliva 
samples may have had only very small amounts of saliva transmitted from the mosquito, so in 
many cases the differences in saliva titers cannot be reasonably compared. The purpose of this 
aspect of the study was less to find out the actual titer of saliva expressed per volume, and more 
	  62	  
as a proof of concept that Cx. tarsalis could, in fact, potentially transmit HJV and that there was 
no salivary gland barrier present. 
 
Table 21: Titers of qRT-PCR positive saliva samples by mosquito 
Head Saliva qRT-PCR Result Log10  pfu equivalents/saliva 
H1 POS 2.73 
H3 POS 2.17 
H6 POS 5.81 
H7 POS 2.48 
H8 POS 2.53 
H11 POS 2.54 
H13 POS 3.98 
H14 POS 1.68 
H15 POS 5.72 
H16 POS 3.92 
H18 POS 2.22 
H28 POS 2.26 
H29 POS 3.55 
H30 POS 5.44 
H31 POS 5.16 
H32 POS 4.47 
H33 POS 5.08 
H40 POS 2.26 
H43 POS 2.89 
H46 POS 3.13 
H47 POS 3.16 
H49 POS 5.74 
  AVERAGE: 5.02 
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This research program was undertaken to further our knowledge of the genetic 
information of HJV and to evaluate the transmission dynamics of HJV.  HJV is unique in that it 
is found on the east coast of the United States, but its closest relative is WEEV.  Due to the facts 
that all isolates of HJV have come from the eastern United States and that Cx. tarsalis pools 
taken from the eastern reaches of their habitat where both mosquito host and virus are present 
have never yielded an isolate, it was broadly assumed that the vectoring capacity of Cx. tarsalis 
was non-existent.  However, no recorded studies examining this tenet could be found in 
published literature.  In fact, there have been very few published studies of any type on HJV, 
mostly because it has not been identified as the causative agent of any disease in humans or 
equids, with the exception of a single case of disease in a horse in Florida in 1964 [27].  With 
limited resources available for scientific research, it was unlikely that a virus of little note for 
human health would be extensively studied, even though it has been shown to be a poultry 
disease of concern [37]. 
 Sequencing of HJV strains available at the CDC yielded four lineages, designated here as 
Lineages 1, 2, 3 and 4.  The lineage 4 strain, WX3-2AP, was the most diverse with a large 
number of nucleotide changes resulting in conservation of amino acid when compared with the 
other strains. In all strains explored, a total of 20 amino acid differences relative to the B230 
strain were recorded, however only 7 of these differences resulted in a change in character of the 
amino acid.  Interestingly, the Lineage 1 strains were isolated between 1960 and 1964, while the 
Lineage 2 strains were newer, isolated between 1973 and 1980.  There are two distinct 
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possibilities for describing the relationship between the older Lineage 1 and newer Lineage 2 
strains.  The first possibility is that there is a common ancestor for the Lineage 1 and 2 strains 
that is not represented in this sample set and that the two lineages diverged from this common 
ancestor to formulate the two branches.  The other possibility is that the Lineage 1 strains 
isolated in the 1960s were direct ancestors to the strains from the 1970s and 1980s.  If this is the 
case, there’s a distinct possibility that the relationship is not easily visible using a limited number 
of isolates.  Additional sequencing of newer strains would be needed to identify modern strains 
associated with direct ancestry in Lineage 1.  Sequencing of additional older strains, if available, 
would be needed to identify a common ancestor of Lineage 1 and Lineage 2. 
Initially, two genetically disparate strains of HJV (B230 and WX3-2AP) were chosen for 
infection studies in Cx. tarsalis.  These strains were chosen because an exhibition of similar 
infection and dissemination rates in these two very different strains could indicate a similarity in 
phenotype among all HJV strains.  Surprisingly, a statistically significant difference between the 
two strains was clearly identified.  Strain B230 had a much lower infection and dissemination 
rate than WX3-2AP, which exhibited infection and dissemination levels similar to those seen in 
WEEV.   
The inclusion of 2 additional strains (AB-80-9 and 64A-1519) in the analysis further 
clarified the differences between strains.  Lineage 2 strain AB-80-9 had high infection and 
dissemination rates similar to the Lineage 4 strain.  Lineage 1 strain 64A-1519, on the other 
hand, had low infection and dissemination rates more similar to B230.  This data showed that 
Lineage 1 strains were both less infectious for Cx. tarsalis compared to the Lineage 2 and 4 
strains.   
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Quantitative RT-PCR was utilized to quantify the total viral load present in the heads and 
bodies of the mosquitoes, and to certify the results of the CPE assays utilized in these 
experiments.  Clear differences in the replication patterns of HJV within Cx. tarsalis were 
identified by examining the dose of virus in various tissues.  Lineage 1 strains showed variable 
infectivity that was not consistent between the two strains.  Lineages 2 and 4, on the other hand, 
had much more regular and predictable patterns with a general increase in viral titer with time. 
In order to examine the presence of a potential salivary gland block to viral transmission, 
strain AB-80-9 was used to orally infect Cx. tarsalis and saliva was collected from infected 
mosquitoes.  qRT-PCR was utilized again to identify and quantify any HJV viral RNA present in 
the saliva.  Viral RNA was, in fact, present in the saliva of these mosquitoes with an average titer 
of 5.02 log10 pfu equivalents/saliva 8 days post-infection.  Exact salivary titers could not be 
calculated because the volume of saliva expressed could not be quantified.  Despite this 
limitation, this study indicates a clear potential for Cx. tarsalis mosquitoes to become infected 
with and to transmit HJV.  
Variations in the genome sequences of the different strains of HJV were explored to 
identify any potentially important amino acids affecting vector competence.  A single amino acid 
difference at genome nucleotide position 8605 (amino acid 69 in the E2 glycoprotein) resulting 
in a Gly-to-Glu shift was identified as potentially responsible for the disparity.  This difference 
replaces a non-polar amino acid with an acidic one.  It has previously been documented that the 
first 260 amino acids of the E2 glycoprotein are located within the ectodomain, and thus on the 
surface of the virion, however some amino acids may be sequestered due to protein folding or 
glycoprotein interactions.  Interestingly, amino acid 60 in SINV was identified as being located 
in antibody binding epitope C indicating that this portion of the glycoprotein is most likely 
	  66	  
exposed on the surface of the virion.  The Gly in B230 and 64A-1519 is the only amino acid 
common to both strains that is not present in the more infectious strains tested.  For further 
clarification and study, a B230 infectious clone is planned for construction using restriction 
enzyme cloning and the amino acid of interest will be introduced using site-directed 
mutagenesis.  Further studies to assess the function of the amino acids at this location are needed 
to ascertain this mutation’s role as the causative genetic element of the disparity. 
Although it is unlikely as important as the difference at genome nucleotide 8605, the 
differences in viral replication patterns between less-infectious strains B230 and 64A-1519 could 
be due to the Val to Ile shift at genome nucleotide position 9243 since that is the only genetic 
difference shared among all other tested strains as compared with B230.  Although this mutation 
results in the maintenance of a non-polar amino acid in that position, the particular amino acid at 
this location could be required for some necessary function or conformation of the E2 
glycoprotein.   
 
Conclusions 
The results of this study raise interesting questions about HJV and WEEV surveillance 
and the impact of possible HJV transmission by Cx. tarsalis in the United States.  It has been 
reported in the literature that there is cross-reactivity between HJV antibody and WEEV antigen 
in EIA, CF, HI, RIP, and PRNT assays [27,76-79], which makes these tests potentially unreliable 
for the differential diagnosis of WEEV in the event of co-circulation of HJV and WEEV.  The 
only tests that can reliably distinguish between HJV and WEEV are molecular-based methods 
such as RT-PCR or qRT-PCR, but these have a stringent requirement that there be virus present 
in the blood of the patient at the time of blood draw. The necessity of timing the blood draw to 
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align with viremia, along with the high costs of running such a test, are prohibitive in many 
cases.  This leads to a heavy reliance on antibody-based testing, such as PRNT, for the diagnosis 
of WEEV and HJV infection and a potential for misdiagnosis due to the cross-reactivity of these 
viruses.  Because HJV has not been reported in the western United States, secondary tests for 
HJV are not regularly performed on samples suspected of being WEEV positive.  The case can 
now be made for additional testing because it has been shown here that Cx. tarsalis is capable of 
transmitting HJV, and thus HJV could be present throughout the distribution of Cx. tarsalis 
mosquitoes. 
Although HJV is not known to cause disease in healthy humans, patients with pre-
existing conditions or those that are immunocompromised could potentially still be at risk.  
Alternatively, even if HJV is not capable of causing symptomatic disease, prior infection with 
HJV could lead to later misdiagnosis of even non-alphaviral encephalitic disease as WEEV due 
to cross-reactive antibody in the sample.  This could lead, for example, to West Nile virus 
(WNV) related encephalitis being misdiagnosed as WEEV because of a positive antibody test 
due to prior HJV infection.   Dual or co-infection of SLEV and HJV has been documented, but 
all symptoms of disease were attributed to SLEV infection [34].  Instances like these lead to 
difficult diagnoses if the appropriate tests are not ordered by knowledgeable medical staff. 
A virtual elimination of human cases of WEEV in the United States in past decades has 
occurred [89].  Notably, there has not been a reported case of WEEV in humans since 1998 in 
the United States or Canada.  It has been proposed that “a significant disturbance in WEEV 
circulation occurred roughly between 1945 and 1965” that the disturbance likely changed the 
selective pressures on WEEV or reduced WEEV populations and/or diversity [89].  Given that 
this study indicated that amino acids likely responsible for more efficient mosquito infection of 
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HJV in Cx. tarsalis have been present as early as 1963 in strain WX3-2AP and the fact that 
antibody induced during HJV infection is partially protective against later challenge by WEEV, 
the potential exists that an undetected enzootic cycle of HJV involving Cx. tarsalis in the United 
States could be responsible for the reduction.  It is unlikely that HJV is capable of significantly 
out-competing WEEV for amplification in the mosquito host as the viruses have very similar 
amplification cycles, but subclinical infection with HJV resulting in a population with some level 
of cross-protective immunity against WEEV is possible. This need not be a large percentage of 
the population, but just enough to disrupt the further transmission of WEEV.  Competition assays 
are needed to assess the competitive fitness of WEEV and HJV in the mosquito host, and 
mammalian cell lines could also be added to assess competitive fitness the vertebrate host cell. 
There has been no similar reduction in the number of cases of EEEV and it is known that 
HJV antibody is not protective against infection with EEEV.  This is primarily due to the 
recombination event that renders the E2 glycoprotein of HJV and WEEV so different from 
EEEV.  This indicates that while an ecological change that disrupts the transmission cycle of 
alphaviral encephalidities, the change appears to be specific to WEEV.  Additionally, there has 
not been a reduction in the numbers of WNV cases in the west and given that WNV is also 




 The discovery of Cx. tarsalis vector competency for HJV suggests potential additional 
research studies.  A HJV strain B230 clone is being produced using a pBluescript II SK(+) 
plasmid vector (Agilent Technologies, Santa Clara, CA) and restriction enzyme cloning.  Once 
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this clone is produced, it will be tested in Cx. tarsalis to ensure that it conserves the parental 
phenotype.  Site-directed mutagenesis will be utilized to introduce the Glu residue common to 
the Lineage 2, 3, and 4 strains into strain B230.  The Glu mutant will be tested in Cx. tarsalis to 
assess infection and dissemination rates as compared with the parental strain.  This process will 
give validation of whether the difference suggested by this research is responsible for the 
differences in infection and dissemination rates shown between Lineage 1 and the other strains. 
 The addition of more HJV strains from various time points and locations would be 
helpful in further characterizing the genetic history of HJV.  Recent strains from New York have 
been identified and characterization of these strains is planned.  More in-depth phylograms could 
be created using these additional strains.  Also, Cx. tarsalis infection patterns could be better 
established using more numerous strains of HJV, especially low passage strains. 
 The use of the established, laboratory-adapted KNWR colony of Cx. tarsalis was ideal 
for manipulation and vector competence studies using artificial blood meals.  However, the use 
of a wild type strain could be more descriptive of the ability of this mosquito vector to transmit 
HJV in the wild.  The addition of infection studies using a newly field-caught strain of mosquito 
could be added to create a more complete picture of vector capacity in nature. 
 Because this study raises interesting questions regarding HJV and WEEV testing in 
endemic areas, it would be interesting to test the sera of humans, equids and birds from endemic 
areas to see if they have been exposed to either, or both, viruses.  A high level of HJV-specific 
antibody would indicate that HJV could have played a role in the reduction of WEEV 
populations.  Historical sera from the 1950s through the 1990s, when WEEV was purportedly in 
decline yet cases were still being reported, could be interesting in comparison to modern 
antibody presence. 
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 As a whole, this research raises interesting questions about strain differences, mosquito 
infection and dissemination, and the interrelatedness of narrowly divergent viruses.  Further 
studies into these complex facets could produce a clear and complete picture of HJV and its role 







1.	   Strauss	   JH,	   Strauss	   EG	   (1994)	   The	   alphaviruses:	   gene	   expression,	   replication,	   and	  
evolution.	  Microbiol	  Rev	  58:	  491-­‐562.	  
2.	   Rice	   CM,	   Strauss	   JH	   (1982)	   Association	   of	   sindbis	   virion	   glycoproteins	   and	   their	  
precursors.	  J	  Mol	  Biol	  154:	  325-­‐348.	  
3.	  Wahlberg	   JM,	   Bron	   R,	  Wilschut	   J,	   Garoff	   H	   (1992)	  Membrane	   fusion	   of	   Semliki	   Forest	  
virus	  involves	  homotrimers	  of	  the	  fusion	  protein.	  J	  Virol	  66:	  7309-­‐7318.	  
4.	  Mukhopadhyay	  S,	  Zhang	  W,	  Gabler	  S,	  Chipman	  PR,	  Strauss	  EG,	  et	  al.	  (2006)	  Mapping	  the	  
structure	  and	  function	  of	  the	  E1	  and	  E2	  glycoproteins	  in	  alphaviruses.	  Structure	  14:	  
63-­‐73.	  
5.	   Jupille	   HJ,	   Medina-­‐Rivera	  M,	   Hawman	   DW,	   Oko	   L,	   Morrison	   TE	   (2013)	   A	   tyrosine-­‐to-­‐
histidine	   switch	   at	   position	   18	   of	   the	   Ross	   River	   virus	   E2	   glycoprotein	   is	   a	  
determinant	  of	  virus	  fitness	  in	  disparate	  hosts.	  J	  Virol	  87:	  5970-­‐5984.	  
6.	  Kinney	  RM,	  Chang	  GJ,	  Tsuchiya	  KR,	  Sneider	  JM,	  Roehrig	   JT,	  et	  al.	   (1993)	  Attenuation	  of	  
Venezuelan	  equine	  encephalitis	  virus	  strain	  TC-­‐83	   is	  encoded	  by	   the	  5'-­‐noncoding	  
region	  and	  the	  E2	  envelope	  glycoprotein.	  J	  Virol	  67:	  1269-­‐1277.	  
7.	   Zhang	  R,	  Hryc	   CF,	   Cong	   Y,	   Liu	   X,	   Jakana	   J,	   et	   al.	   (2011)	   4.4	  A	   cryo-­‐EM	   structure	   of	   an	  
enveloped	  alphavirus	  Venezuelan	  equine	  encephalitis	  virus.	  EMBO	  J	  30:	  3854-­‐3863.	  
8.	  Woodward	  TM,	  Miller	  BR,	  Beaty	  BJ,	   Trent	  DW,	  Roehrig	   JT	   (1991)	  A	   single	   amino	   acid	  
change	   in	   the	   E2	   glycoprotein	   of	   Venezuelan	   equine	   encephalitis	   virus	   affects	  
replication	  and	  dissemination	  in	  Aedes	  aegypti	  mosquitoes.	  J	  Gen	  Virol	  72	  (	  Pt	  10):	  
2431-­‐2435.	  
9.	  Tsetsarkin	  KA,	  McGee	  CE,	  Volk	  SM,	  Vanlandingham	  DL,	  Weaver	  SC,	  et	  al.	  (2009)	  Epistatic	  
roles	   of	   E2	   glycoprotein	   mutations	   in	   adaption	   of	   chikungunya	   virus	   to	   Aedes	  
albopictus	  and	  Ae.	  aegypti	  mosquitoes.	  PLoS	  One	  4:	  e6835.	  
10.	  Zhang	  J,	  Ma	  B,	  DiMaio	  F,	  Douglas	  NR,	  Joachimiak	  LA,	  et	  al.	  (2011)	  Cryo-­‐EM	  structure	  of	  a	  
group	   II	   chaperonin	   in	   the	   prehydrolysis	   ATP-­‐bound	   state	   leading	   to	   lid	   closure.	  
Structure	  19:	  633-­‐639.	  
11.	  Anishchenko	  M,	  Bowen	  RA,	  Paessler	  S,	  Austgen	  L,	  Greene	  IP,	  et	  al.	  (2006)	  Venezuelan	  
encephalitis	   emergence	   mediated	   by	   a	   phylogenetically	   predicted	   viral	   mutation.	  
Proc	  Natl	  Acad	  Sci	  U	  S	  A	  103:	  4994-­‐4999.	  
12.	   Brault	   AC,	   Powers	   AM,	   Holmes	   EC,	  Woelk	   CH,	  Weaver	   SC	   (2002)	   Positively	   charged	  
amino	   acid	   substitutions	   in	   the	   e2	   envelope	   glycoprotein	   are	   associated	  with	   the	  
emergence	  of	  venezuelan	  equine	  encephalitis	  virus.	  J	  Virol	  76:	  1718-­‐1730.	  
13.	  Wang	  E,	  Bowen	  RA,	  Medina	  G,	  Powers	  AM,	  Kang	  W,	  et	  al.	  (2001)	  Virulence	  and	  viremia	  
characteristics	  of	  1992	  epizootic	  subtype	  IC	  Venezuelan	  equine	  encephalitis	  viruses	  
and	  closely	  related	  enzootic	  subtype	  ID	  strains.	  Am	  J	  Trop	  Med	  Hyg	  65:	  64-­‐69.	  
14.	  Mossel	  EC,	  Ledermann	  JP,	  Phillips	  AT,	  Borland	  EM,	  Powers	  AM,	  et	  al.	  (2013)	  Molecular	  
Determinants	  of	  Mouse	  Neurovirulence	  and	  Mosquito	  Infection	  for	  Western	  Equine	  
Encephalitis	  Virus.	  PLoS	  One	  8.	  
15.	   Brault	   AC,	   Powers	   AM,	   Ortiz	   D,	   Estrada-­‐Franco	   JG,	   Navarro-­‐Lopez	   R,	   et	   al.	   (2004)	  
Venezuelan	  equine	  encephalitis	  emergence:	  enhanced	  vector	  infection	  from	  a	  single	  
	  72	  
amino	  acid	  substitution	  in	  the	  envelope	  glycoprotein.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  101:	  
11344-­‐11349.	  
16.	   Tsetsarkin	   KA,	   Vanlandingham	   DL,	   McGee	   CE,	   Higgs	   S	   (2007)	   A	   single	   mutation	   in	  
chikungunya	  virus	  affects	  vector	  specificity	  and	  epidemic	  potential.	  PLoS	  Pathog	  3:	  
e201.	  
17.	   Strauss	   EG,	   Stec	   DS,	   Schmaljohn	   AL,	   Strauss	   JH	   (1991)	   Identification	   of	   antigenically	  
important	   domains	   in	   the	   glycoproteins	   of	   Sindbis	   virus	   by	   analysis	   of	   antibody	  
escape	  variants.	  J	  Virol	  65:	  4654-­‐4664.	  
18.	   Pence	   DF,	   Davis	   NL,	   Johnston	   RE	   (1990)	   Antigenic	   and	   genetic	   characterization	   of	  
Sindbis	   virus	   monoclonal	   antibody	   escape	   mutants	   which	   define	   a	   pathogenesis	  
domain	  on	  glycoprotein	  E2.	  Virology	  175:	  41-­‐49.	  
19.	   Vrati	   S,	   Fernon	   CA,	   Dalgarno	   L,	   Weir	   RC	   (1988)	   Location	   of	   a	   major	   antigenic	   site	  
involved	  in	  Ross	  River	  virus	  neutralization.	  Virology	  162:	  346-­‐353.	  
20.	   Johnson	  BJ,	  Brubaker	   JR,	  Roehrig	   JT,	  Trent	  DW	  (1990)	  Variants	  of	  Venezuelan	  equine	  
encephalitis	  virus	  that	  resist	  neutralization	  define	  a	  domain	  of	  the	  E2	  glycoprotein.	  
Virology	  177:	  676-­‐683.	  
21.	   Powers	   AM,	   Aguilar	   PV,	   Chandler	   LJ,	   Brault	   AC,	   Meakins	   TA,	   et	   al.	   (2006)	   Genetic	  
relationships	   among	   Mayaro	   and	   Una	   viruses	   suggest	   distinct	   patterns	   of	  
transmission.	  Am	  J	  Trop	  Med	  Hyg	  75:	  461-­‐469.	  
22.	  Weaver	  SC,	  Kang	  W,	  Shirako	  Y,	  Rumenapf	  T,	  Strauss	  EG,	  et	  al.	  (1997)	  Recombinational	  
history	   and	   molecular	   evolution	   of	   western	   equine	   encephalomyelitis	   complex	  
alphaviruses.	  J	  Virol	  71:	  613-­‐623.	  
23.	   Allison	   AB,	   Stallknecht	   DE	   (2009)	   Genomic	   sequencing	   of	   Highlands	   J	   virus:	   a	  
comparison	  to	  western	  and	  eastern	  equine	  encephalitis	  viruses.	  Virus	  Res	  145:	  334-­‐
340.	  
24.	   Henderson	   JR,	   Karabatsos	   N,	   Bourke	   AT,	  Wallis	   RC,	   Taylor	   RM	   (1962)	   A	   survey	   for	  
arthropod-­‐borne	  viruses	  in	  south-­‐central	  Florida.	  Am	  J	  Trop	  Med	  Hyg	  11:	  800-­‐810.	  
25.	  Chamberlain	  R,	  Stamm	  DD,	  Coleman	  PH	  (1963)	  Laboratory	  findings	  in	  Tampa	  Bay	  area	  
arbovirus	  investigations,	  1959-­‐1961.	  Fla	  State	  Board	  of	  Health	  Monogr	  5:	  65-­‐68.	  
26.	  Hayes	  CG,	  Wallis	  RC	  (1977)	  Ecology	  of	  Western	  equine	  encephalomyelitis	  in	  the	  eastern	  
United	  States.	  Adv	  Virus	  Res	  21:	  37-­‐83.	  
27.	  Jennings	  WL,	  Allen	  RH,	  Lewis	  AL	  (1966)	  Western	  equine	  encephalomyelitis	  in	  a	  Florida	  
horse.	  Am	  J	  Trop	  Med	  Hyg	  15:	  96-­‐97.	  
28.	   Giltner	   LT,	   Shahan	   MS	   (1933)	   The	   1933	   outbreak	   of	   infectious	   equine	  
encephalomyelitis	  in	  the	  Eastern	  States.	  North	  Am	  Vet	  14:	  25-­‐27.	  
29.	  Webster	   LT,	  Wright	   FH	   (1938)	   Recovery	   of	   Eastern	   Equine	   Encephalomyelitis	   Virus	  
from	   Brain	   Tissue	   of	   Human	   Cases	   of	   Encephalitis	   in	   Massachusetts.	   Science	   88:	  
305-­‐306.	  
30.	   Mohler	   JR	   (1935-­‐1942)	   Reports	   on	   Infectious	   Equine	   Encephalomyelitis	   in	   United	  
States.	  Proc	  Pub	  Bureau	  of	  Animal	  Industries	  issued	  annually.	  
31.	  Howitt	  B	  (1938)	  The	  Recovery	  of	  the	  virus	  of	  Equine	  Encephalomyelitis	  from	  the	  brain	  
of	  a	  child.	  Science	  88:	  455-­‐456.	  
32.	  Leake	   JP	   (1941)	  Epidemic	  of	   Infectious	  Encephalomyelitis.	  Pub	  Health	  Rep	  56:	  1902-­‐
1905.	  
33.	   Karabatsos	   N,	   Lewis	   AL,	   Calisher	   CH,	   Hunt	   AR,	   Roehrig	   JT	   (1988)	   Identification	   of	  
Highlands	  J	  virus	  from	  a	  Florida	  horse.	  Am	  J	  Trop	  Med	  Hyg	  39:	  603-­‐606.	  
	  73	  
34.	  Meehan	  PJ,	  Wells	  DL,	  Paul	  W,	  Buff	  E,	  Lewis	  A,	  et	  al.	  (2000)	  Epidemiological	  features	  of	  
and	  public	  health	  response	   to	  a	  St.	  Louis	  encephalitis	  epidemic	   in	  Florida,	  1990-­‐1.	  
Epidemiol	  Infect	  125:	  181-­‐188.	  
35.	   Jennings	   WL,	   Kathein	   RA,	   Lewis	   AL,	   Bond	   JO	   (1967)	   Encephalitis	   in	   horses	   in	  
Hillsborough	  County,	  Florida,	  1964.	  Am	  J	  Vet	  Res	  28:	  965-­‐970.	  
36.	   Hoff	   GL,	   Bigler	   WJ,	   Buff	   EE,	   Beck	   E	   (1978)	   Occurrence	   and	   distribution	   of	   western	  
equine	  encephalomyelitis	  in	  Florida.	  J	  Am	  Vet	  Med	  Assoc	  172:	  351-­‐352.	  
37.	  Ficken	  MD,	  Wages	  DP,	  Guy	  JS,	  Quinn	  JA,	  Emory	  WH	  (1993)	  High	  mortality	  of	  domestic	  
turkeys	   associated	   with	   Highlands	   J	   virus	   and	   eastern	   equine	   encephalitis	   virus	  
infections.	  Avian	  Dis	  37:	  585-­‐590.	  
38.	   Holden	   P	   (1955)	   Transmission	   of	   eastern	   equine	   encephalitis	   virus	   in	   ring-­‐necked	  
pheasants.	  Proc	  Soc	  Exp	  Biol	  Med	  88:	  607-­‐610.	  
39.	  Striano	  SF,	  Luginbuhl	  RC,	  Wallis	  RC,	  Jungherr	  L,	  Williamson	  LH	  (1958)	  Investigation	  of	  
eastern	   equine	   encephalomyelitis:	   Susceptibility	   and	   transmission	   studies	   with	  
virus	  of	  pheasant	  origin.	  Am	  J	  Hyg	  67:	  21-­‐34.	  
40.	   Guy	   JS,	   Ficken	  MD,	   Barnes	  HJ,	  Wages	  DP,	   Smith	   LG	   (1993)	   Experimental	   infection	   of	  
young	   turkeys	  with	   eastern	  equine	  encephalitis	   virus	   and	  highlands	   J	   virus.	  Avian	  
Dis	  37:	  389-­‐395.	  
41.	  Wages	  DP,	  Ficken	  MD,	  Guy	  JS,	  Cummings	  TS,	  Jennings	  SR	  (1993)	  Egg-­‐production	  drop	  in	  
turkeys	   associated	   with	   alphaviruses:	   eastern	   equine	   encephalitis	   virus	   and	  
Highlands	  J	  virus.	  Avian	  Dis	  37:	  1163-­‐1166.	  
42.	  Eleazer	  TH,	  Hill	  JE	  (1994)	  Highlands	  J	  virus-­‐associated	  mortality	  in	  chukar	  partridges.	  J	  
Vet	  Diagn	  Invest	  6:	  98-­‐99.	  
43.	  McLean	  RG,	  Frier	  G,	  Parham	  GL,	  Francy	  DB,	  Monath	  TP,	  et	  al.	  (1985)	  Investigations	  of	  
the	  vertebrate	  hosts	  of	  eastern	  equine	  encephalitis	  during	  an	  epizootic	  in	  Michigan,	  
1980.	  Am	  J	  Trop	  Med	  Hyg	  34:	  1190-­‐1202.	  
44.	  Scott	  TW,	  Weaver	  SC	  (1989)	  Eastern	  equine	  encephalomyelitis	  virus:	  epidemiology	  and	  
evolution	  of	  mosquito	  transmission.	  Adv	  Virus	  Res	  37:	  277-­‐328.	  
45.	  Reisen	  W.K.	  MTP	  (1988)	  Western	  Equine	  Encephalomyelitis.	  In:	  Monath	  TP,	  editor.	  The	  
Arboviruses:	  epidemiology	  and	  ecology.	  Boca	  Raton,	  FL:	  CRC	  Press,	  Inc.	  pp.	  89-­‐137.	  
46.	   Darsie	   Jr.	   RF,	   Ward	   RA	   (2005)	   Identification	   and	   Geographical	   Distribution	   of	   the	  
Mosquitoes	  of	  North	  America,	  North	  of	  Mexico.	  Gainesville,	  FL:	  University	  Press	  of	  
Florida.	  
47.	  McLean	  RG	  (2005)	  Wildlife	  Diseases	  and	  Humans.	  Internet	  Center	  for	  Wildlife	  Damage	  
Management.	  
48.	  Grady	  GF,	  Maxfield	  HK,	  Hildreth	  SW,	  Timperi	  RJ,	   Jr.,	  Gilfillan	  RF,	  et	  al.	   (1978)	  Eastern	  
equine	   encephalitis	   in	   Massachusetts,	   1957-­‐1976.	   A	   prospective	   study	   centered	  
upon	  analyses	  of	  mosquitoes.	  Am	  J	  Epidemiol	  107:	  170-­‐178.	  
49.	   Morris	   CD,	   Corey	  ME,	   Emord	   DE,	   Howard	   JJ	   (1980)	   Epizootiology	   of	   eastern	   equine	  
encephalomyelitis	  virus	  in	  upstate	  New	  York,	  USA.	  I.	  Introduction,	  demography	  and	  
natural	  environment	  of	  an	  endemic	  focus.	  J	  Med	  Entomol	  17:	  442-­‐452.	  
50.	  Chamberlain	  RW	  (1958)	  Vector	  relationships	  of	  the	  arthropod-­‐borne	  encephalitides	  in	  
North	  America.	  Ann	  N	  Y	  Acad	  Sci	  70:	  312-­‐319.	  
51.	  Altman	  R,	  Goldfield	  M,	  Sussman	  O	  (1967)	  The	  impact	  of	  vector-­‐borne	  viral	  diseases	  in	  
the	  Middle	  Atlantic	  States.	  Med	  Clin	  North	  Am	  51:	  661-­‐671.	  
	  74	  
52.	   Morris	   CD	   (1988)	   Eastern	   Equine	   Encephalomyelitis.	   In:	   Monath	   TP,	   editor.	   The	  
Arboviruses:	  epidemiology	  and	  ecology.	  Boca	  Raton,	  FL:	  CRC	  Press.	  pp.	  1-­‐20.	  
53.	   Takeda	   T,	   Whitehouse	   CA,	   Brewer	   M,	   Gettman	   AD,	   Mather	   TN	   (2003)	   Arbovirus	  
surveillance	   in	  Rhode	  Island:	  assessing	  potential	  ecologic	  and	  climatic	  correlates.	   J	  
Am	  Mosq	  Control	  Assoc	  19:	  179-­‐189.	  
54.	  (2009)	  Medical	  and	  Veterinary	  Entomology;	  Mullen	  GR,	  Durden	  LA,	  editors.	  Burlington,	  
MA:	  Academic	  Press,	  Elsevier.	  637	  p.	  
55.	  Molaei	  G,	  Andreadis	  TG,	  Armstrong	  PM,	  Thomas	  MC,	  Deschamps	  T,	  et	  al.	  (2013)	  Vector-­‐
host	   interactions	   and	   epizootiology	   of	   eastern	   equine	   encephalitis	   virus	   in	  
Massachusetts.	  Vector	  Borne	  Zoonotic	  Dis	  13:	  312-­‐323.	  
56.	   Molaei	   G,	   Oliver	   J,	   Andreadis	   TG,	   Armstrong	   PM,	   Howard	   JJ	   (2006)	   Molecular	  
identification	   of	   blood-­‐meal	   sources	   in	   Culiseta	   melanura	   and	   Culiseta	   morsitans	  
from	  an	  endemic	  focus	  of	  eastern	  equine	  encephalitis	  virus	  in	  New	  York.	  Am	  J	  Trop	  
Med	  Hyg	  75:	  1140-­‐1147.	  
57.	   Molaei	   G,	   Andreadis	   TG	   (2006)	   Identification	   of	   avian-­‐	   and	   mammalian-­‐derived	  
bloodmeals	   in	   Aedes	   vexans	   and	   Culiseta	   melanura	   (Diptera:	   Culicidae)	   and	   its	  
implication	   for	  West	  Nile	   virus	   transmission	   in	   Connecticut,	   U.S.A.	   J	  Med	  Entomol	  
43:	  1088-­‐1093.	  
58.	  Apperson	  CS,	  Hassan	  HK,	  Harrison	  BA,	  Savage	  HM,	  Aspen	  SE,	  et	  al.	  (2004)	  Host	  feeding	  
patterns	   of	   established	   and	   potential	   mosquito	   vectors	   of	   West	   Nile	   virus	   in	   the	  
eastern	  United	  States.	  Vector	  Borne	  Zoonotic	  Dis	  4:	  71-­‐82.	  
59.	  Andreadis	  TG,	  Anderson	  JF,	  Tirrell-­‐Peck	  SJ	  (1998)	  Multiple	  isolations	  of	  eastern	  equine	  
encephalitis	  and	  highlands	  J	  viruses	  from	  mosquitoes	  (Diptera:	  Culicidae)	  during	  a	  
1996	  epizootic	  in	  southeastern	  Connecticut.	  J	  Med	  Entomol	  35:	  296-­‐302.	  
60.	   Wellings	   FM,	   Lewis	   AL,	   Pierce	   LV	   (1972)	   Agents	   encountered	   during	   arboviral	  
ecological	  studies:	  Tampa	  Bay	  area,	  Florida,	  1963	  to	  1970.	  Am	  J	  Trop	  Med	  Hyg	  21:	  
201-­‐213.	  
61.	   Connelly	   CR	   (2004)	   Mosquito-­‐transmitted	   Highlands	   J	   Virus	   in	   Florida.	   In:	   Sciences	  
IoFaA,	  editor.	  3	  ed:	  Entomology	  and	  Nematology	  Department,	  University	  of	  Florida.	  
62.	  Wood	  DM,	  Dang	  PT,	  Ellis	  RA	  (1979)	  The	  Mosquitoes	  of	  Canada.	  
63.	   Rapp	  WF	   (1985)	   The	   distribution	   and	   natural	   history	   of	   Culex	   tarsalis	   in	   the	   Great	  
Plains	  Region.	  29-­‐33	  p.	  
64.	  Crans	  WJ,	  Lesser	  F,	  Candeletti	  T	  (1979)	  Recent	  distribution	  records	  of	  Culex	  tarsalis	  in	  
New	  Jersey.	  Mosquito	  News	  39:	  244-­‐247.	  
65.	  Williams	  JW,	  Cuffee	  PA,	  Foley	  KR,	  Sr.	  (2004)	  Collection	  of	  Culex	  tarsalis	  in	  southeastern	  
Virginia.	  J	  Am	  Mosq	  Control	  Assoc	  20:	  454-­‐455.	  
66.	   Pitcairn	   MJ,	   Wilson	   LT,	   Washino	   RK,	   Rejmankova	   E	   (1994)	   Spatial	   patterns	   of	  
Anopheles	  freeborni	  and	  Culex	  tarsalis	  (Diptera:	  Culicidae)	  larvae	  in	  California	  rice	  
fields.	  J	  Med	  Entomol	  31:	  545-­‐553.	  
67.	   Reisen	   WK,	   Takahashi	   RM,	   Carroll	   BD,	   Quiring	   R	   (2008)	   Delinquent	   mortgages,	  
neglected	   swimming	   pools,	   and	   West	   Nile	   virus,	   California.	   Emerg	   Infect	   Dis	   14:	  
1747-­‐1749.	  
68.	   Patrick	   ML,	   Gonzalez	   RJ,	   Bradley	   TJ	   (2001)	   Sodium	   and	   chloride	   regulation	   in	  
freshwater	  and	  osmoconforming	  larvae	  of	  Culex	  mosquitoes.	  J	  Exp	  Biol	  204:	  3345-­‐
3354.	  
	  75	  
69.	   Edmans	   JD,	   Downe	   AER	   (1964)	   Host	   blood	   sources	   and	  multiple-­‐feeding	   habitats	   of	  
mosquitoes	  in	  Kansas.	  Mosquito	  News	  24:	  154-­‐160.	  
70.	  Reisen	  WK,	  Lothrop	  HD,	  Thiemann	  T	   (2013)	  Host	   selection	  patterns	  of	  Culex	   tarsalis	  
(Diptera:	   Culicidae)	   at	   wetlands	   near	   the	   Salton	   Sea,	   Coachella	   Valley,	   California,	  
1998-­‐2002.	  J	  Med	  Entomol	  50:	  1071-­‐1076.	  
71.	  Durden	  LA,	  Linthicum	  KJ,	  Monath	  TP	  (1993)	  Laboratory	  transmission	  of	  eastern	  equine	  
encephalomyelitis	  virus	  to	  chickens	  by	  chicken	  mites	  (Acari:	  Dermanyssidae).	  J	  Med	  
Entomol	  30:	  281-­‐285.	  
72.	   Howard	   JJ,	   Oliver	   J,	   Grayson	   MA	   (2004)	   Antibody	   response	   of	   wild	   birds	   to	   natural	  
infection	  with	  alphaviruses.	  J	  Med	  Entomol	  41:	  1090-­‐1103.	  
73.	  McLean	  RG	  (1991)	  Arboviruses	  of	  wild	  birds	  and	  mammals.	  Bulletin	  of	  the	  Society	  for	  
Vector	  Ecology	  16.	  
74.	  Main	  AJ,	  Anderson	  KS,	  Maxfield	  HK,	  Rosenau	  B,	  Oliver	  C	  (1988)	  Duration	  of	  Alphavirus	  
neutralizing	  antibody	  in	  naturally	  infected	  birds.	  Am	  J	  Trop	  Med	  Hyg	  38:	  208-­‐217.	  
75.	  Komar	  N,	  Dohm	  DJ,	  Turell	  MJ,	  Spielman	  A	  (1999)	  Eastern	  equine	  encephalitis	  virus	  in	  
birds:	  relative	  competence	  of	  European	  starlings	  (Sturnus	  vulgaris).	  Am	  J	  Trop	  Med	  
Hyg	  60:	  387-­‐391.	  
76.	  Hildreth	  SW,	  Beaty	  BJ,	  Maxfield	  HK,	  Gilfillan	  RF,	  Rosenau	  BJ	  (1984)	  Detection	  of	  eastern	  
equine	   encephalomyelitis	   virus	   and	   Highlands	   J	   virus	   antigens	   within	   mosquito	  
pools	   by	   enzyme	   immunoassay	   (EIA).	   II.	   Retrospective	   field	   test	   of	   the	   EIA.	   Am	   J	  
Trop	  Med	  Hyg	  33:	  973-­‐980.	  
77.	  Karabatsos	  N	   (1985)	   International	  Catalogue	  of	  Arboviruses	   (Including	  Certain	  Other	  
Viruses	  of	  Vertebrates).	  In:	  Hygiene	  ASoTMa,	  editor.	  San	  Antonio,	  TX.	  
78.	  Trent	  DW,	  Grant	   JA	   (1980)	  A	   comparison	  of	  New	  World	   alphaviruses	   in	   the	  western	  
equine	   encephalomyelitis	   complex	   by	   immunochemical	   and	   oligonucleotide	  
fingerprint	  techniques.	  J	  Gen	  Virol	  47:	  261-­‐282.	  
79.	  Calisher	  CH,	  Karabatsos	  N,	  Lazuick	  JS,	  Monath	  TP,	  Wolff	  KL	  (1988)	  Reevaluation	  of	  the	  
western	  equine	  encephalitis	  antigenic	  complex	  of	  alphaviruses	  (family	  Togaviridae)	  
as	  determined	  by	  neutralization	  tests.	  Am	  J	  Trop	  Med	  Hyg	  38:	  447-­‐452.	  
80.	  Hahn	  CS,	  Lustig	  S,	  Strauss	  EG,	  Strauss	  JH	  (1988)	  Western	  equine	  encephalitis	  virus	  is	  a	  
recombinant	  virus.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  85:	  5997-­‐6001.	  
81.	   Weaver	   SC	   (1995)	   Evolution	   of	   Alphaviruses.	   In:	   Gibbs	   AJC,	   C.H.;	   Garcia-­‐Arenal,	   F,	  
editor.	  Molecular	   Basics	   of	   Virus	   Evolution.	   Cambridge,	   UK:	   Cambridge	  University	  
Press.	  pp.	  501-­‐530.	  
82.	  Weaver	  SCR-­‐H,	  R;	  Scott,	  T.W.	  (1992)	  Genetic	  Diversity	  and	  Slow	  Rates	  of	  Evolution	  in	  
New	  World	  Alphaviruses.	  Current	  Topics	  in	  Microbiology	  and	  Immunology	  176:	  99-­‐
117.	  
83.	   Weaver	   SCB,	   L.A.;	   Hagenbaugh,	   A.;	   Mallampalli,	   V.;	   Holland,	   J.J.;	   Scott,	   T.W.	   (1994)	  
Evolution	  of	  Alphaviruses	  in	  the	  eastern	  equine	  encephalomyelitis	  complex.	  Journal	  
of	  Virology	  68:	  158-­‐169.	  
84.	   Cilnis	   MJ,	   Kang	   W,	   Weaver	   SC	   (1996)	   Genetic	   conservation	   of	   Highlands	   J	   viruses.	  
Virology	  218:	  343-­‐351.	  
85.	  Linnen	   JM,	  Vinelli	  E,	  Sabino	  EC,	  Tobler	  LH,	  Hyland	  C,	  et	  al.	   (2008)	  Dengue	  Viremia	   in	  
Blood	  Donors	  from	  Honduras,	  Brazil	  and	  Australia.	  Transfusion	  48:	  1355-­‐1362.	  
	  76	  
86.	   Vazeille	   M,	   Moutliller	   S,	   Coudrier	   D,	   Rousseaux	   C,	   Khun	   H,	   et	   al.	   (2007)	   Two	  
Chikungunya	   Isolates	   from	   the	   Outbreak	   of	   La	   Reunion	   (Indian	   Ocean)	   Exhibit	  
Different	  Patterns	  of	  Infection	  in	  the	  Mosquito.	  PLOS	  One	  2:	  1168.	  
87.	  Collins	  W,	  Harrison	  A,	  Jumper	  J	  (1965)	  Infection	  and	  transmission	  studies	  with	  eastern	  
encephalitis	   virus	   in	   Anopheles	   albimanus	   and	   Anopheles	   quadrimaculatus.	  
Mosquito	  News	  25:	  296-­‐300.	  
88.	  Weaver	  SC,	  Scott	  TW,	  Lorenz	  LH	  (1990)	  Patterns	  of	  eastern	  equine	  encephalomyelitis	  
virus	   infection	   in	   Culiseta	  melanura	   (Diptera:	   Culicidae).	   J	  Med	   Entomol	   27:	   878-­‐
891.	  
89.	   Bergren	   N,	   Auguste	   A,	   Forrester	   N,	   Neigi	   S,	   Braun	  W,	   et	   al.	   (2014)	  Western	   Equine	  
Encephalitis	   Virus:	   Evolutionary	   analysis	   of	   a	   declining	   alphavirus	   based	   on	  
complete	  genome	  sequences.	  J	  Virol	  88:	  9260-­‐9267.	  
	   	  
	  77	  


























Feed 1 5.80 
4 40 13 6 32.5 15.0 46.2 
Lineage 
1 
8 43 13 11 30.2 25.6 84.6 
11 42 9 7 21.4 16.7 77.8 
Blood 
Feed 2 6.31 
4 38 18 15 44.7 39.5 83.3 
8 40 13 11 32.5 27.5 84.6 
11 34 12 9 35.3 26.5 75.0 
Combined 
Data 6.05 
4 78 31 21 39.7 26.9 67.7 
8 83 26 22 31.3 26.5 84.6 
11 76 21 16 27.6 21.1 76.2 




Feed 1 6.01 
4 37 15 10 40.5 27.0 66.7 
Lineage 
1 
8 40 12 11 30.0 27.5 91.7 
11 40 15 14 37.5 35.0 93.3 
Blood 
Feed 2 5.81 
4 38 8 5 21.1 13.2 62.5 
8 40 6 6 15.0 15.0 100.0 
11 40 10 10 25.0 25.0 100.0 
Combined 
Data 5.91 
4 75 23 15 30.7 20.0 65.2 
8 80 18 17 22.5 21.3 94.4 
11 80 25 24 31.3 30.0 96.0 




Feed 1 5.70 
4 35 24 12 68.6 34.3 50.0 
Lineage 
4 
8 45 33 31 73.3 68.9 93.9 
11 35 29 26 82.9 74.3 89.7 
Blood 
Feed 2 5.84 
4 38 29 13 76.3 34.2 44.8 
8 39 26 21 66.7 53.8 80.8 
11 30 22 20 73.3 66.7 90.9 
Combined 
Data 5.77 
4 73 53 25 72.6 34.2 47.2 
8 84 59 52 70.2 61.9 88.1 
11 65 51 46 78.5 70.8 90.2 




Feed 1 6.32 
4 37 30 11 81.1 29.7 36.7 
Lineage 
2 
8 40 32 23 80.0 57.5 71.9 
11 23 18 17 78.3 73.9 94.4 
Blood 
Feed 2 6.08 
4 38 33 17 86.8 44.7 51.5 
8 40 35 31 87.5 77.5 88.6 
11 40 28 27 70.0 67.5 96.4 
Combined 
Data 6.20 
4 75 63 28 84.0 37.3 44.4 
8 80 67 54 83.8 67.5 80.6 
11 63 46 44 73.0 69.8 95.7 
# Diss- Number of Mosquitoes with Disseminated Infection; % Diss- % Disseminated; %Diss of Infected- % Disseminated 
of Those Mosquitoes Infected 
 
